0001047469-19-006367.txt : 20191118 0001047469-19-006367.hdr.sgml : 20191118 20191118171719 ACCESSION NUMBER: 0001047469-19-006367 CONFORMED SUBMISSION TYPE: S-3ASR PUBLIC DOCUMENT COUNT: 9 FILED AS OF DATE: 20191118 DATE AS OF CHANGE: 20191118 EFFECTIVENESS DATE: 20191118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PEPSICO INC CENTRAL INDEX KEY: 0000077476 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] IRS NUMBER: 131584302 STATE OF INCORPORATION: NC FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: S-3ASR SEC ACT: 1933 Act SEC FILE NUMBER: 333-234767 FILM NUMBER: 191228365 BUSINESS ADDRESS: STREET 1: 700 ANDERSON HILL RD CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 9142532000 MAIL ADDRESS: STREET 1: 700 ANDERSON HILL ROAD CITY: PURCHASE STATE: NY ZIP: 10577-1444 FORMER COMPANY: FORMER CONFORMED NAME: PEPSI COLA CO DATE OF NAME CHANGE: 19700903 S-3ASR 1 a2240066zs-3asr.htm S-3ASR

Use these links to rapidly review the document
TABLE OF CONTENTS

Table of Contents

As filed with the Securities and Exchange Commission on November 18, 2019

Registration No. 333-            


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933



PepsiCo, Inc.
(Exact Name of Registrant as Specified in Its Charter)

North Carolina
(State or Other Jurisdiction of
Incorporation or Organization)
  13-1584302
(I.R.S. Employer
Identification Number)

700 Anderson Hill Road
Purchase, New York 10577
(914) 253-2000

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices)



David Yawman
Executive Vice President, Government Affairs,
General Counsel and Corporate Secretary
PepsiCo, Inc.
700 Anderson Hill Road
Purchase, New York 10577
(914) 253-2000
Fax: (914) 253-3051

(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)



Copy to:

Joseph A. Hall
Davis Polk & Wardwell LLP
450 Lexington Avenue
New York, NY 10017
(212) 450-4000
Fax: (212) 450-4800



Approximate date of commencement of proposed sale to the public: From time to time after this registration statement becomes effective.

           If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. o

           If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ý

           If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

           If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. o

           If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ý

           If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. o

           Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ý   Accelerated filer o   Non-accelerated filer o   Smaller reporting company o

Emerging growth company o

           If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. o



CALCULATION OF REGISTRATION FEE

       
 
Title of Each Class of Securities
to Be Registered

  Amount to Be Registered/
Proposed Maximum Offering Price Per Unit/
Proposed Maximum Aggregate Offering Price(1)

  Amount of
Registration Fee(1)

 

Common stock, par value 1-2/3 cents per share

       
 

Debt securities

       
 

Warrants

       
 

Units

       

 

(1)
An indeterminate aggregate initial offering price and number or amount of the securities of each identified class is being registered as may from time to time be sold at indeterminate prices. In accordance with Rules 456(b) and 457(r), the registrant is deferring payment of all of the registration fee.

   


Table of Contents

PROSPECTUS

LOGO

COMMON STOCK
DEBT SECURITIES
WARRANTS
UNITS



        We may offer from time to time common stock, debt securities, warrants or units. Specific terms of these securities will be provided in supplements to this prospectus. You should read this prospectus and any supplement carefully before you invest.

        Investing in these securities involves certain risks. See the information included and incorporated by reference in this prospectus and any accompanying prospectus supplement for a discussion of the factors you should carefully consider before deciding to purchase these securities, including the information under "Risk Factors" beginning on page 3 of this prospectus and "Risk Factors" and "Our Business Risks" included in our annual report on Form 10-K for the fiscal year ended December 29, 2018, in our quarterly report on Form 10-Q for the 12 weeks ended March 23, 2019, in our quarterly report on Form 10-Q for the 12 and 24 weeks ended June 15, 2019, and in our quarterly report on Form 10-Q for the 12 and 36 weeks ended September 7, 2019.



        Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

   

The date of this prospectus is November 18, 2019.


Table of Contents

        We have not authorized anyone to provide any information other than that contained or incorporated by reference in this prospectus, in any accompanying prospectus supplement or in any free writing prospectus filed by us with the Securities and Exchange Commission (the "SEC"). We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are not making an offer to sell these securities in any jurisdiction where the offer and sale is not permitted. You should not assume that the information contained in or incorporated by reference in this prospectus or any accompanying prospectus supplement or in any such free writing prospectus or in any document incorporated by reference is accurate as of any date other than their respective dates. Our business, financial condition, results of operations and prospects may have changed since those dates.

        As used in this prospectus, unless otherwise specified or where it is clear from the context that the term only means the issuer, the terms "PepsiCo," the "Company," "we," "us," and "our" refer to PepsiCo, Inc. and its consolidated subsidiaries. All references in this prospectus to "$" and "dollars" are to U.S. dollars.




TABLE OF CONTENTS

i


Table of Contents


THE COMPANY

        We were incorporated in Delaware in 1919 and reincorporated in North Carolina in 1986. We are a leading global food and beverage company with a complementary portfolio of brands, including Frito-Lay, Gatorade, Pepsi-Cola, Quaker and Tropicana. Through our operations, authorized bottlers, contract manufacturers and other third parties, we make, market, distribute and sell a wide variety of convenient beverages, foods and snacks, serving customers and consumers in more than 200 countries and territories.

        Our principal executive offices are located at 700 Anderson Hill Road, Purchase, New York 10577 and our telephone number is (914) 253-2000. We maintain a website at www.pepsico.com where general information about us is available. We are not incorporating the contents of the website into this prospectus or any accompanying prospectus supplement.


ABOUT THIS PROSPECTUS

        This prospectus is part of a registration statement that we filed with the SEC utilizing a "shelf" registration process. Under this shelf process, we may sell any combination of the securities described in this prospectus in one or more offerings. This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will contain specific information about the terms of that offering. The prospectus supplement may also add, update or change information contained in this prospectus. You should read both this prospectus and any prospectus supplement together with additional information described under the heading "Where You Can Find More Information."


WHERE YOU CAN FIND MORE INFORMATION

        We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains an Internet site that contains reports, proxy and information statements and other information that we file electronically with the SEC at http://www.sec.gov, from which interested persons can electronically access the registration statement, of which this prospectus is a part, including the exhibits and schedules thereto.

        The SEC allows us to "incorporate by reference" information into this prospectus, which means that we can disclose important information to you by referring you to documents that we file with the SEC. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update, modify and, where applicable, supersede the information contained in this prospectus or incorporated by reference into this prospectus. We incorporate by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules), on or after the date of this prospectus until we sell all of the securities covered by our registration statement, of which this prospectus forms a part:

1


Table of Contents

        You may request a copy of these filings at no cost, by writing or telephoning the office of Manager, Shareholder Relations, PepsiCo, Inc., 700 Anderson Hill Road, Purchase, New York 10577, (914) 253-3055, investor@pepsico.com.


SPECIAL NOTE ON FORWARD-LOOKING STATEMENTS

        This prospectus and any accompanying prospectus supplement, including the documents incorporated by reference herein and therein, contain statements reflecting our views about our future performance that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Statements that constitute forward-looking statements within the meaning of the Reform Act are generally identified through the inclusion of words such as "aim," "anticipate," "believe," "drive," "estimate," "expect," "expressed confidence," "forecast," "future," "goal," "guidance," "intend," "may," "objective," "outlook," "plan," "position," "potential," "project," "seek," "should," "strategy," "target," "will" or similar statements or variations of such words and other similar expressions. All statements addressing our future operating performance, and statements addressing events and developments that we expect or anticipate will occur in the future, are forward-looking statements within the meaning of the Reform Act. These forward-looking statements are based on currently available information, operating plans and projections about future events and trends. They inherently involve risks and uncertainties that could cause actual results to differ materially from those predicted in any such forward-looking statement. These risks and uncertainties include, but are not limited to, those described in "Risk Factors" included herein and "Risk Factors" and "Our Business Risks" in our annual report on Form 10-K for the fiscal year ended December 29, 2018, in our quarterly report on Form 10-Q for the 12 weeks ended March 23, 2019, in our quarterly report on Form 10-Q for the 12 and 24 weeks ended June 15, 2019, and in our quarterly report on Form 10-Q for the 12 and 36 weeks ended September 7, 2019, and in any subsequent annual report on Form 10-K, quarterly report on Form 10-Q or current report on Form 8-K incorporated by reference herein or in any accompanying prospectus supplement. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. The discussion of risks included or incorporated by reference in this prospectus or any accompanying prospectus supplement is by no means all-inclusive but is designed to highlight what we believe are important factors to consider when evaluating our future performance.

2


Table of Contents


RISK FACTORS

        Investing in these securities involves risks. Prior to deciding to purchase any securities, prospective investors should consider carefully all of the information set forth in this prospectus and the applicable prospectus supplement, any free writing prospectus filed by us with the SEC and the documents incorporated by reference herein. In particular, you should carefully consider the factors discussed below and under "Risk Factors" and "Our Business Risks" in our annual report on Form 10-K for the fiscal year ended December 29, 2018, in our quarterly report on Form 10-Q for the 12 weeks ended March 23, 2019, in our quarterly report on Form 10-Q for the 12 and 24 weeks ended June 15, 2019, and in our quarterly report on Form 10-Q for the 12 and 36 weeks ended September 7, 2019.

Risks Relating to Floating Rate Notes

        When a prospectus supplement offers floating rate notes, as described under "Description of Debt Securities—Floating Rate Notes," the following risk factors will apply.

         Uncertainty relating to the calculation of the U.S. dollar three-month London Interbank Offered Rate ("LIBOR") and other reference rates and their potential discontinuance may materially adversely affect the value of the floating rate notes.

        National and international regulators and law enforcement agencies have conducted investigations into a number of rates or indices which are deemed to be "reference rates." Actions by such regulators and law enforcement agencies may result in changes to the manner in which certain reference rates are determined, their discontinuance, or the establishment of alternative reference rates. In particular, on July 27, 2017, the Chief Executive of the U.K. Financial Conduct Authority (the "FCA"), which regulates LIBOR, announced that the FCA will no longer persuade or compel banks to submit rates for the calculation of LIBOR after 2021. Such announcement indicates that the continuation of LIBOR on the current basis cannot and will not be guaranteed after 2021.

        At this time, it is not possible to predict the effect that these developments, any discontinuance, modification or other reforms to LIBOR or any other reference rate, or the establishment of alternative reference rates may have on LIBOR, other benchmarks or floating rate debt securities, including the floating rate notes. Uncertainty as to the nature of such potential discontinuance, modification, alternative reference rates or other reforms may materially adversely affect the trading market for securities linked to such benchmarks, including the floating rate notes. Furthermore, the use of alternative reference rates or other reforms could cause the interest rate calculated for the floating rate notes to be materially different than expected.

        If it is determined that LIBOR has been discontinued and an alternative reference rate for LIBOR is used as described in "Description of Debt Securities—Floating Rate Notes—Interest Periods and Interest Rate," PepsiCo (or our designee, each, a "Designee") may make certain adjustments to such rate, including applying a spread thereon or with respect to the business day convention, interest determination dates and related provisions and definitions, to make such alternative reference rate comparable to LIBOR, in a manner that is consistent with industry-accepted practices or applicable regulatory or legislative actions or guidance for such alternative reference rate. See "Description of Debt Securities—Floating Rate Notes—Interest Periods and Interest Rate." Any of the specified methods of determining floating rate alternative reference rates or the permitted adjustments to such rates may result in interest payments on your floating rate notes that are lower than or that do not otherwise correlate over time with the payments that would have been made on the floating rate notes if published LIBOR continued to be available. Other floating rate debt securities issued by other issuers, by comparison, may be subject in similar circumstances to different procedures for the establishment of alternative reference rates. Any of the foregoing may have a material adverse effect on

3


Table of Contents

the amount of interest payable on your floating rate notes, or the market liquidity and market value of your floating rate notes.

         Interest on the floating rate notes will be calculated using a Benchmark Replacement selected by PepsiCo or our Designee if a Benchmark Transition Event occurs.

        As described in detail in the section "Description of Debt Securities—Floating Rate Notes—Interest Periods and Interest Rate—Effect of Benchmark Transition Event" (the "benchmark transition provisions"), if during the term of the floating rate notes, PepsiCo (or our Designee) determines that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to LIBOR, PepsiCo (or our Designee) in its sole discretion will select a Benchmark Replacement as the base rate in accordance with the benchmark transition provisions. The Benchmark Replacement will include a spread adjustment, and technical, administrative or operational changes described in the benchmark transition provisions may be made to the interest rate determination if PepsiCo (or our Designee) determines in its sole discretion they are required.

        The interests of PepsiCo (or our Designee) in making the determinations described above may be adverse to your interests as a holder of floating rate notes. The selection of a Benchmark Replacement, and any decisions made by PepsiCo (or our Designee) in connection with implementing a Benchmark Replacement with respect to the floating rate notes, could result in adverse consequences to the applicable interest rate on the floating rate notes, which could adversely affect the return on, value of and market for such securities. Further, there is no assurance that the characteristics of any Benchmark Replacement will be similar to LIBOR or that any Benchmark Replacement will produce the economic equivalent of LIBOR.

         The Secured Overnight Financing Rate ("SOFR") is a relatively new market index and as the related market continues to develop, there may be an adverse effect on the return on or value of the floating rate notes.

        If a Benchmark Transition Event and its related Benchmark Replacement Date occur, then the rate of interest on the floating rate notes will be determined using SOFR (unless a Benchmark Transition Event and its related Benchmark Replacement Date also occur with respect to the Benchmark Replacements that are linked to SOFR, in which case the rate of interest will be based on the next-available Benchmark Replacement). In the following discussion of SOFR, when we refer to SOFR-linked notes or debt securities, we mean the floating rate notes at any time when the rate of interest on those notes or debt securities is or will be determined based on SOFR.

        The Benchmark Replacements specified in the benchmark transition provisions include Term SOFR, a forward-looking term rate which will be based on the Secured Overnight Financing Rate. Term SOFR is currently being developed under the sponsorship of the Federal Reserve Bank of New York (the "NY Federal Reserve"), and there is no assurance that the development of Term SOFR will be completed. If a Benchmark Transition Event and its related Benchmark Replacement Date occur with respect to LIBOR and, at that time, a form of Term SOFR has not been selected or recommended by the Federal Reserve Board, the NY Federal Reserve, a committee thereof or successor thereto, then the next-available Benchmark Replacement under the benchmark transition provisions will be used to determine the amount of interest payable on the floating rate notes for the next applicable interest period and all subsequent interest periods (unless a Benchmark Transition Event and its related Benchmark Replacement Date occur with respect to that next-available Benchmark Replacement).

        These replacement rates and adjustments may be selected or formulated by (i) the Relevant Governmental Body (as defined in the benchmark transition provisions) (such as the Alternative Reference Rates Committee of the NY Federal Reserve), (ii) the International Swaps and Derivatives

4


Table of Contents

Association, Inc., or (iii) in certain circumstances, PepsiCo (or our Designee). In addition, the benchmark transition provisions expressly authorize PepsiCo (or our Designee) to make Benchmark Replacement Conforming Changes with respect to, among other things, the determination of interest periods and the timing and frequency of determining rates and making payments of interest. The application of a Benchmark Replacement and Benchmark Replacement Adjustment, and any implementation of Benchmark Replacement Conforming Changes, could result in adverse consequences to the amount of interest payable on the floating rate notes, which could adversely affect the return on, value of and market for the floating rate notes. Further, there is no assurance that the characteristics of any Benchmark Replacement will be similar to the then-current Benchmark that it is replacing, or that any Benchmark Replacement will produce the economic equivalent of the then-current Benchmark that it is replacing.

        The NY Federal Reserve began to publish SOFR in April 2018. Although the NY Federal Reserve has also begun publishing historical indicative SOFR going back to 2014, such prepublication historical data inherently involves assumptions, estimates and approximations. You should not rely on any historical changes or trends in SOFR as an indicator of the future performance of SOFR. Since the initial publication of SOFR, daily changes in the rate have, on occasion, been more volatile than daily changes in comparable benchmark or market rates. As a result, the return on and value of SOFR-linked debt securities may fluctuate more than floating rate debt securities that are linked to less volatile rates.

        Also, since SOFR is a relatively new market index, SOFR-linked debt securities likely will have no established trading market when issued, and an established trading market may never develop or may not be very liquid. Market terms for debt securities indexed to SOFR, such as the spread over the index reflected in interest rate provisions, may evolve over time, and trading prices of the floating rate notes may be lower than those of later-issued SOFR-linked debt securities as a result. Similarly, if SOFR does not prove to be widely used in securities like the floating rate notes, the trading price of those securities may be lower than those of debt securities linked to rates that are more widely used. Debt securities indexed to SOFR may not be able to be sold or may not be able to be sold at prices that will provide a yield comparable to similar investments that have a developed secondary market, and may consequently suffer from increased pricing volatility and market risk.

        The NY Federal Reserve notes on its publication page for SOFR that use of SOFR is subject to important limitations, indemnification obligations and disclaimers, including that the NY Federal Reserve may alter the methods of calculation, publication schedule, rate revision practices or availability of SOFR at any time without notice. There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to you as a holder of floating rate notes. If the manner in which SOFR is calculated is changed or if SOFR is discontinued, that change or discontinuance may result in a reduction or elimination of the amount of interest payable on the floating rate notes and a reduction in their trading prices.


USE OF PROCEEDS

        Unless otherwise indicated in a prospectus supplement, the net proceeds from the sale of the securities will be used for general corporate purposes.

5


Table of Contents


DESCRIPTION OF COMMON STOCK

        The following description of our common stock is based upon our Amended and Restated Articles of Incorporation, effective as of May 1, 2019 ("Articles of Incorporation"), our By-Laws, as amended and restated, effective as of January 11, 2016 ("By-Laws") and applicable provisions of law. We have summarized certain portions of the Articles of Incorporation and By-Laws below. The summary is not complete. The Articles of Incorporation and By-Laws are incorporated by reference as exhibits to the registration statement of which this prospectus forms a part. You should read the Articles of Incorporation and By-Laws for the provisions that are important to you.

General

        Our Articles of Incorporation authorize us to issue 3,600,000,000 shares of common stock, par value one and two-thirds cents (1-2/3 cents) per share. As of September 26, 2019 there were 1,394,435,338 shares of common stock outstanding which were held of record by 110,778 shareholders.

        Voting Rights.    Each holder of a share of our common stock is entitled to one vote for each share held of record on the applicable record date on each matter submitted to a vote of shareholders. Action on a matter generally requires that the votes cast in favor of the action exceed the votes cast in opposition. A plurality vote is required in an election of the Board of Directors where the number of director nominees exceeds the number of directors to be elected.

        Dividend Rights.    Holders of our common stock are entitled to receive dividends as may be declared from time to time by PepsiCo's Board of Directors out of funds legally available therefor.

        Rights Upon Liquidation.    Holders of our common stock are entitled to share pro rata, upon any liquidation, dissolution or winding up of PepsiCo, in all remaining assets available for distribution to shareholders after payment or providing for PepsiCo's liabilities.

        Preemptive Rights.    Holders of our common stock do not have the right to subscribe for, purchase or receive new or additional common stock or other securities.

Transfer Agent and Registrar

        Computershare Trust Company, N.A. is the transfer agent and registrar for our common stock.

Stock Exchange Listing

        The Nasdaq Global Select Market is the principal market for our common stock, which is also listed on the SIX Swiss Exchange.

Certain Provisions of PepsiCo's Articles of Incorporation and By-Laws; Director Indemnification Agreements

        Advance Notice of Proposals and Nominations.    Our By-Laws provide that shareholders must provide timely written notice to bring business before an annual meeting of shareholders or to nominate candidates for election as directors at an annual meeting of shareholders. Notice for an annual meeting is generally timely if it is received at our principal office not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year's annual meeting. However, if the date of the annual meeting is advanced by more than 30 days or delayed more than 60 days from this anniversary date, or if no annual meeting was held in the preceding year, such notice by the shareholder must be delivered not earlier than the 120th day prior to the annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or the tenth day following the day on which public announcement of the date of such annual meeting was first made. Shareholders utilizing "proxy access" must meet separate deadlines. The By-Laws also specify the form

6


Table of Contents

and content of a shareholder's notice. These provisions may prevent shareholders from bringing matters before an annual meeting of shareholders or from nominating candidates for election as directors at an annual meeting of shareholders.

        Proxy Access.    Our By-Laws contain "proxy access" provisions which give an eligible shareholder (or a group of up to 20 shareholders aggregating their shares) that has owned 3% or more of the outstanding common stock continuously for at least three years the right to nominate the greater of two nominees and 20% of the number of directors to be elected at the applicable annual general meeting, and to have those nominees included in our proxy materials, subject to the other terms and conditions of our By-Laws.

        Special Meetings.    A special meeting of the shareholders may be called by the Chairman of the Board, by resolution of the Board or by our corporate secretary upon written request of one or more shareholders holding shares of record representing at least twenty percent in the aggregate of our outstanding common stock entitled to vote at such meeting. Any such special meeting called at the request of our shareholders will be held at such date, time and place as may be fixed by our Board, provided that the date of such special meeting may not be more than 90 days from the receipt of such request by the corporate secretary. The By-Laws specify the form and content of a shareholder's request for a special meeting.

        Indemnification of Directors, Officers and Employees.    Our By-Laws provide that unless the Board determines otherwise, we shall indemnify, to the full extent permitted by law, any person who was or is, or who is threatened to be made, a party to an action, suit or proceeding (including appeals), whether civil, criminal, administrative, investigative or arbitrative, by reason of the fact that such person, such person's testator or intestate, is or was one of our directors, officers or employees, or is or was serving at our request as a director, officer or employee of another enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding. Pursuant to our By-Laws this indemnification may, at the Board's discretion, also include advancement of expenses prior to the final disposition of such action, suit or proceeding.

        In addition, we have entered into indemnification agreements with each of our independent directors, pursuant to which we have agreed to indemnify and hold harmless, to the full extent permitted by law, each director against any and all liabilities and assessments (including attorneys' fees and other costs, expenses and obligations) arising out of or related to any threatened, pending or completed action, suit, proceeding, inquiry or investigation, whether civil, criminal, administrative, or other, including, but not limited to, judgments, fines, penalties and amounts paid in settlement (whether with or without court approval), and any interest, assessments, excise taxes or other charges paid or payable in connection with or in respect of any of the foregoing, incurred by the independent director and arising out of his status as a director or member of a committee of our Board, or by reason of anything done or not done by the director in such capacities. After receipt of an appropriate request by an independent director, we will also advance all expenses, costs and other obligations (including attorneys' fees) arising out of or related to such matters. We will not be liable for payment of any liability or expense incurred by an independent director on account of acts which, at the time taken, were known or believed by such director to be clearly in conflict with our best interests.

Certain Anti-Takeover Effects of North Carolina Law

        The North Carolina Shareholder Protection Act generally requires the affirmative vote of 95% of a public corporation's voting shares to approve a "business combination" with any entity that a majority of continuing directors determines beneficially owns, directly or indirectly, more than 20% of the voting shares of the corporation (or ever owned, directly or indirectly, more than 20% and is still an

7


Table of Contents

"affiliate" of the corporation) unless the fair price provisions and the procedural provisions of the North Carolina Shareholder Protection Act are satisfied.

        "Business combination" is defined by the North Carolina Shareholder Protection Act as (i) any merger, consolidation or conversion of a corporation with or into any other entity, or (ii) any sale or lease of all or any substantial part of the corporation's assets to any other entity, or (iii) any payment, sale or lease to the corporation or any subsidiary thereof in exchange for securities of the corporation of any assets having an aggregate fair market value equal to or greater than $5,000,000 of any other entity.

        The North Carolina Shareholder Protection Act contains provisions that allowed a corporation to "opt out" of the applicability of the North Carolina Shareholder Protection Act's voting provisions within specified time periods that generally have expired. The Act applies to PepsiCo since we did not opt out within these time periods.

        This statute could discourage a third party from making a partial tender offer or otherwise attempting to obtain a substantial position in our equity securities or seeking to obtain control of us. It also might limit the price that certain investors might be willing to pay in the future for our shares of common stock and may have the effect of delaying or preventing a change of control of us.

8


Table of Contents


DESCRIPTION OF DEBT SECURITIES

        This prospectus describes certain general terms and provisions of the debt securities. The debt securities will be issued under an indenture dated as of May 21, 2007 between us and The Bank of New York Mellon, as trustee. When we offer to sell a particular series of debt securities, we will describe the specific terms for the securities in a supplement to this prospectus. The prospectus supplement will also indicate whether the general terms and provisions described in this prospectus apply to a particular series of debt securities.

        We have summarized certain terms and provisions of the indenture. The summary is not complete. The indenture has been incorporated by reference as an exhibit to the registration statement for these securities that we have filed with the SEC. You should read the indenture for the provisions which may be important to you. The indenture is subject to and governed by the Trust Indenture Act of 1939, as amended.

        The indenture does not limit the amount of debt securities which we may issue. We may issue debt securities up to an aggregate principal amount as we may authorize from time to time. The prospectus supplement will describe the terms of any debt securities being offered, including:

    classification as senior or subordinated debt securities;

    ranking of the specific series of debt securities relative to other outstanding indebtedness, including subsidiaries' debt;

    if the debt securities are subordinated, the aggregate amount of outstanding indebtedness, as of a recent date, that is senior to the subordinated securities, and any limitation on the issuance of additional senior indebtedness;

    the designation, aggregate principal amount and authorized denominations;

    the maturity date;

    the interest rate, if any, and the method for calculating the interest rate;

    the interest payment dates and the record dates for the interest payments;

    any mandatory or optional redemption terms or prepayment, conversion, sinking fund or exchangeability or convertibility provisions;

    the place where we will pay principal and interest;

    if other than denominations of $1,000 or multiples of $1,000, the denominations the debt securities will be issued in;

    whether the debt securities will be issued in the form of global securities or certificates;

    the inapplicability of and additional provisions, if any, relating to the defeasance of the debt securities;

    the currency or currencies, if other than the currency of the United States, in which principal and interest will be paid;

    any material United States federal income tax consequences;

    the dates on which premium, if any, will be paid;

    our right, if any, to defer payment of interest and the maximum length of this deferral period;

    any listing on a securities exchange;

    the initial public offering price; and

    other specific terms, including any additional events of default or covenants.

9


Table of Contents

Senior Debt

        Senior debt securities will rank equally and pari passu with all other unsecured and unsubordinated debt of PepsiCo.

Subordinated Debt

        Subordinated debt securities will be subordinate and junior in right of payment, to the extent and in the manner set forth in the indenture, to all "senior indebtedness" of PepsiCo. The indenture defines "senior indebtedness" as obligations or indebtedness of, or guaranteed or assumed by, PepsiCo for borrowed money whether or not represented by bonds, debentures, notes or other similar instruments, and amendments, renewals, extensions, modifications and refundings of any such indebtedness or obligation. "Senior indebtedness" does not include nonrecourse obligations, the subordinated debt securities or any other obligations specifically designated as being subordinate in right of payment to senior indebtedness.

        In general, the holders of all senior indebtedness are first entitled to receive payment of the full amount unpaid on senior indebtedness before the holders of any of the subordinated debt securities or coupons are entitled to receive a payment on account of the principal or interest on the indebtedness evidenced by the subordinated debt securities in certain events. These events include:

    any insolvency or bankruptcy proceedings, or any receivership, liquidation, reorganization or other similar proceedings which concern PepsiCo or a substantial part of its property;

    a default having occurred for the payment of principal, premium, if any, or interest on or other monetary amounts due and payable on any senior indebtedness or any other default having occurred concerning any senior indebtedness, which permits the holder or holders of any senior indebtedness to accelerate the maturity of any senior indebtedness with notice or lapse of time, or both. Such an event of default must have continued beyond the period of grace, if any, provided for such event of default, and such an event of default shall not have been cured or waived or shall not have ceased to exist; or

    the principal of, and accrued interest on, any series of the subordinated debt securities having been declared due and payable upon an event of default pursuant to section 5.02 of the indenture. This declaration must not have been rescinded and annulled as provided in the indenture.

        If this prospectus is being delivered in connection with a series of subordinated debt securities, the applicable prospectus supplement or the information incorporated in this prospectus by reference will set forth the approximate amount of senior indebtedness outstanding as of the end of the most recent fiscal quarter.

Floating Rate Notes

        When the debt securities of any U.S. dollar-denominated series bear interest at a variable or floating rate (referred to below as "floating rate notes"), unless the applicable prospectus supplement states otherwise, the following provisions will apply to the calculation of interest in respect of such floating rate notes.

    Calculation Agent

        The Bank of New York Mellon will act as calculation agent for the floating rate notes under an Amended and Restated Calculation Agency Agreement between the issuer and The Bank of New York Mellon dated as of May 10, 2011.

10


Table of Contents

    Interest Payment Dates

        Interest on the floating rate notes will be payable quarterly in arrears on the interest payment dates set forth in the applicable prospectus supplement, commencing on the date set forth in the applicable prospectus supplement to the persons in whose names the notes are registered at the close of business on each record date set forth in the applicable prospectus supplement, as the case may be (whether or not a New York business day (as defined below)). If any interest payment date (other than the maturity date or any earlier repayment date) falls on a day that is not a New York business day, the payment of interest that would otherwise be payable on such date will be postponed to the next succeeding New York business day, except that if such New York business day falls in the next succeeding calendar month, the applicable interest payment date will be the immediately preceding New York business day. If the maturity date or any earlier repayment date of the floating rate notes falls on a day that is not a New York business day, the payment of principal, premium, if any, and interest, if any, otherwise payable on such date will be postponed to the next succeeding New York business day, and no interest on such payment will accrue from and after the maturity date or earlier repayment date, as applicable.

        A "New York business day" is any day other than a Saturday, Sunday or other day on which commercial banks are required or permitted by law, regulation or executive order to be closed in New York City.

    Interest Reset Dates

        The interest rate will be reset quarterly on the interest reset dates set forth in the applicable prospectus supplement, commencing on the date set forth in the applicable prospectus supplement. However, if any interest reset date would otherwise be a day that is not a New York business day, such interest reset date will be the next succeeding day that is a New York business day, except that if the next succeeding New York business day falls in the next succeeding calendar month, the applicable interest reset date will be the immediately preceding New York business day.

    Interest Periods and Interest Rate

        The initial interest period will be the period from and including the date set forth in the applicable prospectus supplement to but excluding the first interest reset date. The interest rate in effect during the initial interest period will be equal to LIBOR plus the amount set forth in the applicable prospectus supplement, determined two London business days prior to the date set forth in the applicable prospectus supplement. A "London business day" is a day on which dealings in deposits in U.S. dollars are transacted in the London interbank market.

        After the initial interest period, the interest periods will be the periods from and including an interest reset date to but excluding the immediately succeeding interest reset date, except that the final interest period will be the period from and including the interest reset date immediately preceding the maturity date to but excluding the maturity date. The interest rate per annum for the floating rate notes in any interest period will be equal to LIBOR plus the amount set forth in the applicable prospectus supplement, as determined by the calculation agent. The interest rate in effect for the 15 calendar days prior to any repayment date earlier than the maturity date will be the interest rate in effect on the fifteenth day preceding such earlier repayment date.

        The interest rate on the floating rate notes will be limited to the maximum rate permitted by New York law, as the same may be modified by United States law of general application.

        Upon the request of any holder of floating rate notes, the calculation agent will provide the interest rate then in effect and, if determined, the interest rate that will become effective on the next interest reset date.

11


Table of Contents

        The calculation agent will determine LIBOR for each interest period on the second London business day prior to the first day of such interest period.

        LIBOR, with respect to any interest determination date, will be the offered rate for deposits of U.S. dollars having a maturity of three months that appears on Bloomberg L.P.'s page "BBAM" (or such other page as may replace that page on that service) at approximately 11:00 a.m., London time, on such interest determination date.

        If no offered rate appears on Bloomberg L.P. page "BBAM" on an interest determination date, LIBOR will be determined for such interest determination date on the basis of the rates at approximately 11:00 a.m., London time, on such interest determination date at which deposits in U.S. dollars are offered to prime banks in the London inter-bank market by four major banks in such market selected by PepsiCo, for a term of three months commencing on the applicable interest reset date and in a principal amount equal to an amount that in the judgment of the calculation agent is representative for a single transaction in U.S. dollars in such market at such time. The calculation agent will request the principal London office of each of such banks to provide a quotation of its rate. If at least two such quotations are provided, LIBOR for such interest period will be the arithmetic mean of such quotations. If fewer than two such quotations are provided, LIBOR for such interest period will be the arithmetic mean of the rates quoted at approximately 11:00 a.m. in New York City on such interest determination date by three major banks in New York City, selected by PepsiCo, for loans in U.S. dollars to leading European banks, for a term of three months commencing on the applicable interest reset date and in a principal amount equal to an amount that in the judgment of the calculation agent is representative for a single transaction in U.S. dollars in such market at such time; provided, however, that if the banks so selected are not quoting as mentioned above, the then-existing LIBOR rate will remain in effect for such interest period, or, if none, the interest rate will be the initial interest rate.

        Notwithstanding the foregoing two paragraphs, if PepsiCo (or our designee, each, a "Designee") determines on or prior to the relevant interest determination date that a Benchmark Transition Event and its related Benchmark Replacement Date (each, as defined below) have occurred with respect to LIBOR, then the provisions set forth below under "Effect of Benchmark Transition Event," which is referred to as the "benchmark transition provisions," will thereafter apply to all determinations of the rate of interest payable on the floating rate notes. In accordance with the benchmark transition provisions, after a Benchmark Transition Event and its related Benchmark Replacement Date have occurred, the amount of interest that will be payable for each interest period will be an annual rate equal to the sum of the Benchmark Replacement (as defined below) and the margin specified in the applicable prospectus supplement.

    Effect of Benchmark Transition Event

        Benchmark Replacement.    If PepsiCo or our Designee determines that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to the Reference Time in respect of any determination of the Benchmark on any date, the Benchmark Replacement will replace the then-current Benchmark for all purposes relating to the floating rate notes in respect of such determination on such date and all determinations on all subsequent dates.

        Benchmark Replacement Conforming Changes.    In connection with the implementation of a Benchmark Replacement, PepsiCo (or our Designee) will have the right to make Benchmark Replacement Conforming Changes from time to time.

        Decisions and Determinations.    Any determination, decision or election that may be made by PepsiCo (or our Designee) pursuant to the benchmark transition provisions, including any determination with respect to a tenor, rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error, will be made in PepsiCo's (or our Designee's) sole

12


Table of Contents

discretion, and, notwithstanding anything to the contrary in the documentation relating to the floating rate notes, shall become effective without consent from holders or beneficial owners of the floating rate notes or any other party.

        Certain Defined Terms.    As used in the benchmark transition provisions:

        "Benchmark" means, initially, LIBOR; provided that if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to LIBOR or the then-current Benchmark, then "Benchmark" means the applicable Benchmark Replacement.

        "Benchmark Replacement" means the Interpolated Benchmark; provided that if PepsiCo (or our Designee) cannot determine the Interpolated Benchmark as of the Benchmark Replacement Date, then "Benchmark Replacement" means the first alternative set forth in the order below that can be determined by PepsiCo (or our Designee) as of the Benchmark Replacement Date:

            (1)   the sum of: (a) Term SOFR and (b) the Benchmark Replacement Adjustment;

            (2)   the sum of: (a) Compounded SOFR and (b) the Benchmark Replacement Adjustment;

            (3)   the sum of: (a) the alternate rate of interest that has been selected or recommended by the Relevant Governmental Body as the replacement for the then-current Benchmark for the applicable Corresponding Tenor and (b) the Benchmark Replacement Adjustment;

            (4)   the sum of: (a) the ISDA Fallback Rate and (b) the Benchmark Replacement Adjustment;

            (5)   the sum of: (a) the alternate rate of interest that has been selected by PepsiCo (or our Designee) as the replacement for the then-current Benchmark for the applicable Corresponding Tenor giving due consideration to any industry-accepted rate of interest as a replacement for the then-current Benchmark for U.S. dollar denominated floating rate notes at such time and (b) the Benchmark Replacement Adjustment.

        "Benchmark Replacement Adjustment" means the first alternative set forth in the order below that can be determined by PepsiCo (or our Designee) as of the Benchmark Replacement Date:

            (1)   the spread adjustment, or method for calculating or determining such spread adjustment (which may be a positive or negative value or zero), that has been selected or recommended by the Relevant Governmental Body for the applicable Unadjusted Benchmark Replacement;

            (2)   if the applicable Unadjusted Benchmark Replacement is equivalent to the ISDA Fallback Rate, then the ISDA Fallback Adjustment;

            (3)   the spread adjustment (which may be a positive or negative value or zero) that has been selected by PepsiCo (or our Designee) giving due consideration to any industry-accepted spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of the then-current Benchmark with the applicable Unadjusted Benchmark Replacement for U.S. dollar denominated floating rate notes at such time.

        "Benchmark Replacement Conforming Changes" means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of "Interest Period," timing and frequency of determining rates and making payments of interest, and other administrative matters) that PepsiCo (or our Designee) decides may be appropriate to reflect the adoption of such Benchmark Replacement in a manner substantially consistent with market practice (or, if PepsiCo (or our Designee) decides that adoption of any portion of such market practice is not administratively feasible or if PepsiCo (or our Designee) determines that no market practice for use of the Benchmark Replacement exists, in such other manner as PepsiCo (or our Designee) determines is reasonably necessary).

13


Table of Contents

        "Benchmark Replacement Date" means the earliest to occur of the following events with respect to the then-current Benchmark:

            (1)   in the case of clause (1) or (2) of the definition of "Benchmark Transition Event," the later of (a) the date of the public statement or publication of information referenced therein and (b) the date on which the administrator of the Benchmark permanently or indefinitely ceases to provide the Benchmark; or

            (2)   in the case of clause (3) of the definition of "Benchmark Transition Event," the date of the public statement or publication of information referenced therein.

For the avoidance of doubt, if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination.

        "Benchmark Transition Event" means the occurrence of one or more of the following events with respect to the then-current Benchmark:

            (1)   a public statement or publication of information by or on behalf of the administrator of the Benchmark announcing that such administrator has ceased or will cease to provide the Benchmark, permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the Benchmark;

            (2)   a public statement or publication of information by the regulatory supervisor for the administrator of the Benchmark, the central bank for the currency of the Benchmark, an insolvency official with jurisdiction over the administrator for the Benchmark, a resolution authority with jurisdiction over the administrator for the Benchmark or a court or an entity with similar insolvency or resolution authority over the administrator for the Benchmark, which states that the administrator of the Benchmark has ceased or will cease to provide the Benchmark permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the Benchmark; or

            (3)   a public statement or publication of information by the regulatory supervisor for the administrator of the Benchmark announcing that the Benchmark is no longer representative.

        "Compounded SOFR" means the compounded average of SOFRs for the applicable Corresponding Tenor, with the rate, or methodology for this rate, and conventions for this rate being established by PepsiCo (or our Designee) in accordance with:

            (1)   the rate, or methodology for this rate, and conventions for this rate selected or recommended by the Relevant Governmental Body for determining compounded SOFR; provided that:

            (2)   if, and to the extent that, PepsiCo (or our Designee) determines that Compounded SOFR cannot be determined in accordance with clause (1) above, then the rate, or methodology for this rate, and conventions for this rate that have been selected by PepsiCo (or our Designee) giving due consideration to any industry-accepted market practice for U.S. dollar denominated floating rate notes at such time.

        "Corresponding Tenor" with respect to a Benchmark Replacement means a tenor (including overnight) having approximately the same length (disregarding business day adjustment) as the applicable tenor for the then-current Benchmark.

        "Federal Reserve Bank of New York's Website" means the website of the Federal Reserve Bank of New York at http://www.newyorkfed.org, or any successor source.

        "Interpolated Benchmark" with respect to the Benchmark means the rate determined for the Corresponding Tenor by interpolating on a linear basis between: (1) the Benchmark for the longest

14


Table of Contents

period (for which the Benchmark is available) that is shorter than the Corresponding Tenor and (2) the Benchmark for the shortest period (for which the Benchmark is available) that is longer than the Corresponding Tenor.

        "ISDA Definitions" means the 2006 ISDA Definitions published by the International Swaps and Derivatives Association, Inc. or any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time.

        "ISDA Fallback Adjustment" means the spread adjustment (which may be a positive or negative value or zero) that would apply for derivatives transactions referencing the ISDA Definitions to be determined upon the occurrence of an index cessation event with respect to the Benchmark for the applicable tenor.

        "ISDA Fallback Rate" means the rate that would apply for derivatives transactions referencing the ISDA Definitions to be effective upon the occurrence of an index cessation date with respect to the Benchmark for the applicable tenor excluding the applicable ISDA Fallback Adjustment.

        "Reference Time" with respect to any determination of the Benchmark means (1) if the Benchmark is LIBOR, 11:00 a.m. (London time) on the day that is two London banking days preceding the date of such determination, and (2) if the Benchmark is not LIBOR, the time determined by PepsiCo (or our Designee) in accordance with the Benchmark Replacement Conforming Changes.

        "Relevant Governmental Body" means the Federal Reserve Board and/or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and/or the Federal Reserve Bank of New York or any successor thereto.

        "SOFR" with respect to any day means the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark (or a successor administrator), on the Federal Reserve Bank of New York's Website.

        "Term SOFR" means the forward-looking term rate for the applicable Corresponding Tenor based on SOFR that has been selected or recommended by the Relevant Governmental Body.

        "Unadjusted Benchmark Replacement" means the Benchmark Replacement excluding the Benchmark Replacement Adjustment.

        All percentages resulting from any calculation of any interest rate for the floating rate notes will be rounded, if necessary, to the nearest one hundred thousandth of a percentage point, with five one-millionths of a percentage point rounded upward (e.g., 5.876545% (or .05876545) would be rounded to 5.87655% (or .0587655)), and all U.S. dollar amounts will be rounded to the nearest cent, with one-half cent being rounded upward. Each calculation of the interest rate on the floating rate notes by the calculation agent will (in the absence of manifest error) be final and binding on the noteholders and PepsiCo.

    Accrued Interest

        Accrued interest on the floating rate notes will be calculated by multiplying the principal amount of the floating rate notes by an accrued interest factor. This accrued interest factor will be computed by adding the interest factors calculated for each day in the period for which interest is being paid. The interest factor for each day is computed by dividing the interest rate applicable to that day by 360. For these calculations, the interest rate in effect on any reset date will be the applicable rate as reset on that date. The interest rate applicable to any other day is the interest rate from the immediately preceding reset date or, if none, the initial interest rate.

15


Table of Contents

Events of Default

        When we use the term "Event of Default" in the indenture with respect to the debt securities of any series, here are some examples of what we mean:

            (1)   default in paying interest on the debt securities when it becomes due and the default continues for a period of 30 days or more;

            (2)   default in paying principal, or premium, if any, on the debt securities when due;

            (3)   default is made in the payment of any sinking or purchase fund or analogous obligation when the same becomes due, and such default continues for 30 days or more;

            (4)   default in the performance, or breach, of any covenant or warranty of PepsiCo in the indenture (other than defaults specified in clause (1), (2) or (3) above) and the default or breach continues for a period of 90 days or more after we receive written notice from the trustee or we and the trustee receive notice from the holders of at least 51% in aggregate principal amount of the outstanding debt securities of the series;

            (5)   certain events of bankruptcy, insolvency, reorganization, administration or similar proceedings with respect to PepsiCo have occurred; or

            (6)   any other Events of Default set forth in the prospectus supplement.

        If an Event of Default (other than an Event of Default specified in clause (5) with respect to PepsiCo) under the indenture occurs with respect to the debt securities of any series and is continuing, then the trustee or the holders of at least 51% in principal amount of the outstanding debt securities of that series may by written notice require us to repay immediately the entire principal amount of the outstanding debt securities of that series (or such lesser amount as may be provided in the terms of the securities), together with all accrued and unpaid interest and premium, if any.

        If an Event of Default under the indenture specified in clause (5) with respect to PepsiCo occurs and is continuing, then the entire principal amount of the outstanding debt securities (or such lesser amount as may be provided in the terms of the securities) will automatically become due and payable immediately without any declaration or other act on the part of the trustee or any holder.

        After a declaration of acceleration, the holders of not less than 51% in aggregate principal amount of outstanding debt securities of any series may rescind this accelerated payment requirement if all existing Events of Default, except for nonpayment of the principal and interest on the debt securities of that series that has become due solely as a result of the accelerated payment requirement, have been cured or waived and if the rescission of acceleration would not conflict with any judgment or decree. The holders of a majority in principal amount of the outstanding debt securities of any series also have the right to waive past defaults, except a default in paying principal, premium or interest on any outstanding debt security, or in respect of a covenant or a provision that cannot be modified or amended without the consent of all holders of the debt securities of that series.

        Holders of at least 51% in principal amount of the outstanding debt securities of a series may seek to institute a proceeding only after they have notified the Trustee of a continuing Event of Default in writing and made a written request, and offered reasonable indemnity, to the trustee to institute a proceeding and the trustee has failed to do so within 60 days after it received this notice. In addition, within this 60-day period the trustee must not have received directions inconsistent with this written request by holders of a majority in principal amount of the outstanding debt securities of that series. These limitations do not apply, however, to a suit instituted by a holder of a debt security for the enforcement of the payment of principal, interest or any premium on or after the due dates for such payment.

        During the existence of an Event of Default, the trustee is required to exercise the rights and powers vested in it under the indenture and use the same degree of care and skill in its exercise as a

16


Table of Contents

prudent man would under the circumstances in the conduct of that person's own affairs. If an Event of Default has occurred and is continuing, the trustee is not under any obligation to exercise any of its rights or powers at the request or direction of any of the holders unless the holders have offered to the trustee reasonable security or indemnity. Subject to certain provisions, the holders of a majority in principal amount of the outstanding debt securities of any series have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust, or power conferred on the trustee.

        The trustee will, within 90 days after any default occurs, give notice of the default to the holders of the debt securities of that series, unless the default was already cured or waived. Unless there is a default in paying principal, interest or any premium when due, the trustee can withhold giving notice to the holders if it determines in good faith that the withholding of notice is in the interest of the holders.

Modification and Waiver

        The indenture may be amended or modified without the consent of any holder of debt securities in order to:

    evidence a succession to the Trustee;

    cure ambiguities, defects or inconsistencies;

    provide for the assumption of our obligations in the case of a merger or consolidation or transfer of all or substantially all of our assets;

    make any change that would provide any additional rights or benefits to the holders of the debt securities of a series;

    add guarantors with respect to the debt securities of any series;

    secure the debt securities of a series;

    establish the form or forms of debt securities of any series;

    maintain the qualification of the indenture under the Trust Indenture Act; or

    make any change that does not adversely affect in any material respect the interests of any holder.

        Other amendments and modifications of the indenture or the debt securities issued may be made with the consent of the holders of not less than a majority of the aggregate principal amount of the outstanding debt securities of each series affected by the amendment or modification. However, no modification or amendment may, without the consent of the holder of each outstanding debt security affected:

    reduce the principal amount, interest or premium payable, or extend the fixed maturity, of the debt securities;

    alter or waive the redemption provisions of the debt securities;

    change the currency in which principal, any premium or interest is paid;

    reduce the percentage in principal amount outstanding of debt securities of any series which must consent to an amendment, supplement or waiver or consent to take any action;

    impair the right to institute suit for the enforcement of any payment on the debt securities;

    waive a payment default with respect to the debt securities or any guarantor;

    reduce the interest rate or extend the time for payment of interest on the debt securities;

    adversely affect the ranking of the debt securities of any series; or

17


Table of Contents

    release any guarantor from any of its obligations under its guarantee or the indenture, except in compliance with the terms of the indenture.

Covenants

    Limitation of Liens Applicable to Senior Debt Securities

        The indenture provides that with respect to senior debt securities, unless otherwise provided in a particular series of senior debt securities, we will not, and will not permit any of our restricted subsidiaries to, incur, suffer to exist or guarantee any debt secured by a lien on any principal property or on any shares of stock of (or other interests in) any of our restricted subsidiaries unless we or that first-mentioned restricted subsidiary secures or causes such restricted subsidiary to secure the senior debt securities (and any of its or such restricted subsidiary's other debt, at its option or such restricted subsidiary's option, as the case may be, not subordinate to the senior debt securities), equally and ratably with (or prior to) such secured debt, for as long as such secured debt will be so secured.

        These restrictions will not, however, apply to debt secured by:

    (1)
    any liens existing prior to the issuance of such senior debt securities;

    (2)
    any lien on property of or shares of stock of (or other interests in) or debt of any entity existing at the time such entity becomes a restricted subsidiary;

    (3)
    any liens on property, shares of stock of (or other interests in) or debt of any entity (a) existing at the time of acquisition of such property or shares (or other interests) (including acquisition through merger or consolidation), (b) to secure the payment of all or any part of the purchase price of such property or shares (or other interests) or construction or improvement of such property or (c) to secure any debt incurred prior to, at the time of, or within 365 days after the later of the acquisition, the completion of construction or the commencement of full operation of such property or within 365 days after the acquisition of such shares (or other interests) for the purpose of financing all or any part of the purchase price of such shares (or other interests) or construction thereon;

    (4)
    any liens in favor of us or any of our restricted subsidiaries;

    (5)
    any liens in favor of, or required by contracts with, governmental entities; or

    (6)
    any extension, renewal, or refunding of liens referred to in any of the preceding clauses (1) through (5).

        Notwithstanding the foregoing, we or any of our restricted subsidiaries may incur, suffer to exist or guarantee any debt secured by a lien on any principal property or on any shares of stock of (or other interests in) any of our restricted subsidiaries if, after giving effect thereto, the aggregate amount of such debt does not exceed 15% of our consolidated net tangible assets.

        The indenture does not restrict the transfer by us of a principal property to any of our unrestricted subsidiaries or our ability to change the designation of a subsidiary owning principal property from a restricted subsidiary to an unrestricted subsidiary and, if we were to do so, any such unrestricted subsidiary would not be restricted from incurring secured debt nor would we be required, upon such incurrence, to secure the debt securities equally and ratably with such secured debt.

        Definitions.    The following are definitions of some terms used in the above description. We refer you to the indenture for a full description of all of these terms, as well as any other terms used herein for which no definition is provided.

        "Consolidated net tangible assets" means the total amount of our assets and our restricted subsidiaries' assets minus:

    all applicable depreciation, amortization and other valuation reserves;

18


Table of Contents

    all current liabilities of ours and our restricted subsidiaries (excluding any intercompany liabilities); and

    all goodwill, trade names, trademarks, patents, unamortized debt discount and expenses and other like intangibles, all as set forth on our and our restricted subsidiaries' latest consolidated balance sheets prepared in accordance with U.S. generally accepted accounting principles.

        "Debt" means any indebtedness for borrowed money.

        "Principal property" means any single manufacturing or processing plant, office building or warehouse owned or leased by us or any of our restricted subsidiaries other than a plant, warehouse, office building or portion thereof which, in the opinion of our Board of Directors, is not of material importance to the business conducted by us and our restricted subsidiaries taken as an entirety.

        "Restricted subsidiary" means, at any time, any subsidiary which at the time is not an unrestricted subsidiary of ours.

        "Subsidiary" means any entity, at least a majority of the outstanding voting stock of which shall at the time be owned, directly or indirectly, by us or by one or more of our subsidiaries, or both.

        "Unrestricted subsidiary" means any subsidiary of ours (not at the time designated as our restricted subsidiary) (1) the major part of whose business consists of finance, banking, credit, leasing, insurance, financial services or other similar operations, or any combination thereof, (2) substantially all the assets of which consist of the capital stock of one or more subsidiaries engaged in the operations referred to in the preceding clause (1), or (3) designated as an unrestricted subsidiary by our Board of Directors.

    Consolidation, Merger or Sale of Assets

        The indenture provides that we may consolidate or merge with or into, or convey or transfer all or substantially all of our assets to, any entity (including, without limitation, a limited partnership or a limited liability company); provided that:

    we will be the surviving corporation or, if not, that the successor will be a corporation that is organized and validly existing under the laws of any state of the United States of America or the District of Columbia and will expressly assume by a supplemental indenture our obligations under the indenture and the debt securities;

    immediately after giving effect to such transaction, no event of default, and no default or other event which, after notice or lapse of time, or both, would become an event of default, will have happened and be continuing; and

    we will have delivered to the trustee an opinion of counsel, stating that such consolidation, merger, conveyance or transfer complies with the indenture.

In the event of any such consolidation, merger, conveyance, transfer or lease, any such successor will succeed to and be substituted for us as obligor on the debt securities with the same effect as if it had been named in the indenture as obligor, and we will be released from all obligations under the indenture and under the debt securities.

        There are no other restrictive covenants contained in the indenture. The indenture does not contain any provision that will restrict us from entering into one or more additional indentures providing for the issuance of debt securities or warrants, or from incurring, assuming, or becoming liable with respect to any indebtedness or other obligation, whether secured or unsecured, or from paying dividends or making other distributions on our capital stock, or from purchasing or redeeming our capital stock. The indenture does not contain any financial ratios or specified levels of net worth or liquidity to which we must adhere. In addition, the indenture does not contain any provision that would require us to repurchase, redeem, or otherwise modify the terms of any of the debt securities upon a

19


Table of Contents

change in control or other event involving us that may adversely affect our creditworthiness or the value of the debt securities.

Satisfaction, Discharge and Covenant Defeasance

        We may terminate our obligations under the indenture, when:

    either:

    all debt securities of any series issued that have been authenticated and delivered have been delivered to the trustee for cancellation; or

    all the debt securities of any series issued that have not been delivered to the trustee for cancellation have become due and payable, will become due and payable within one year, or are to be called for redemption within one year and we have made arrangements satisfactory to the trustee for the giving of notice of redemption by such trustee in our name and at our expense, and in each case, we have irrevocably deposited or caused to be deposited with the trustee sufficient funds to pay and discharge the entire indebtedness on the series of debt securities to pay principal, interest and any premium; and

    we have paid or caused to be paid all other sums then due and payable under the indenture; and

    we have delivered to the trustee an officers' certificate and an opinion of counsel, each stating that all conditions precedent under the indenture relating to the satisfaction and discharge of the indenture have been complied with.

        We may elect to have our obligations under the indenture discharged with respect to the outstanding debt securities of any series ("legal defeasance"). Legal defeasance means that we will be deemed to have paid and discharged the entire indebtedness represented by the outstanding debt securities of such series under the indenture, except for:

    the rights of holders of the debt securities to receive principal, interest and any premium when due;

    our obligations with respect to the debt securities concerning issuing temporary debt securities, registration of transfer of debt securities, mutilated, destroyed, lost or stolen debt securities and the maintenance of an office or agency for payment for security payments held in trust;

    the rights, powers, trusts, duties and immunities of the trustee; and

    the defeasance provisions of the indenture.

        In addition, we may elect to have our obligations released with respect to certain covenants in the indenture ("covenant defeasance"). Any omission to comply with these obligations will not constitute a default or an event of default with respect to the debt securities of any series. In the event covenant defeasance occurs, certain events, not including non-payment, bankruptcy and insolvency events, described under "Events of Default" above will no longer constitute an event of default for that series.

        In order to exercise either legal defeasance or covenant defeasance with respect to outstanding debt securities of any series:

    we must irrevocably have deposited or caused to be deposited with the trustee as trust funds for the purpose of making the following payments, specifically pledged as security for, and dedicated solely to the benefit of the holders of the debt securities of a series:

    money in an amount;

    U.S. government obligations (or equivalent government obligations in the case of debt securities denominated in other than U.S. dollars or a specified currency) that will provide, not later than one day before the due date of any payment, money in an amount; or

20


Table of Contents

      a combination of money and U.S. government obligations (or equivalent government obligations, as applicable),

      in each case sufficient, in the written opinion (with respect to U.S. or equivalent government obligations or a combination of money and U.S. or equivalent government obligations, as applicable) of a nationally recognized firm of independent registered public accountants, to pay and discharge, and which shall be applied by the trustee to pay and discharge, all of the principal (including mandatory sinking fund payments), interest and any premium at the due date or maturity;

    in the case of legal defeasance, we must have delivered to the trustee an opinion of counsel stating that, under then applicable federal income tax law, the holders of the debt securities of that series will not recognize income, gain or loss for federal income tax purposes as a result of the deposit, defeasance and discharge to be effected and will be subject to the same federal income tax as would be the case if the deposit, defeasance and discharge did not occur;

    in the case of covenant defeasance, we must have delivered to the trustee an opinion of counsel to the effect that the holders of the debt securities of that series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the deposit and covenant defeasance to be effected and will be subject to the same federal income tax as would be the case if the deposit and covenant defeasance did not occur;

    no event of default or default with respect to the outstanding debt securities of that series has occurred and is continuing at the time of such deposit after giving effect to the deposit or, in the case of legal defeasance, no default relating to bankruptcy or insolvency has occurred and is continuing at any time on or before the 91st day after the date of such deposit, it being understood that this condition is not deemed satisfied until after the 91st day;

    the legal defeasance or covenant defeasance will not cause the trustee to have a conflicting interest within the meaning of the Trust Indenture Act, assuming all debt securities of a series were in default within the meaning of such Act;

    the legal defeasance or covenant defeasance will not result in a breach or violation of, or constitute a default under, any other agreement or instrument to which we are a party;

    the legal defeasance or covenant defeasance will not result in the trust arising from such deposit constituting an investment company within the meaning of the Investment Company Act of 1940, as amended, unless the trust is registered under such Act or exempt from registration; and

    we must have delivered to the trustee an officers' certificate and an opinion of counsel stating that all conditions precedent with respect to the legal defeasance or covenant defeasance have been complied with.

Concerning Our Relationship With the Trustee

        We and our subsidiaries maintain banking relationships with The Bank of New York Mellon, which serves as trustee under certain indentures related to other securities that we or our subsidiaries have issued.

21


Table of Contents


DESCRIPTION OF WARRANTS

        We may issue warrants to purchase our debt or equity securities or securities of third parties or other rights, including rights to receive payment in cash or securities based on the value, rate or price of one or more specified commodities, currencies, securities or indices, or any combination of the foregoing. Warrants may be issued independently or together with any other securities and may be attached to, or separate from, such securities. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent. The terms of any warrants to be issued and a description of the material provisions of the applicable warrant agreement will be set forth in the applicable prospectus supplement.

        The applicable prospectus supplement will describe the following terms of any warrants in respect of which this prospectus is being delivered:

    the title of such warrants;

    the aggregate number of such warrants;

    the price or prices at which such warrants will be issued;

    the currency or currencies in which the price of such warrants will be payable;

    the securities or other rights, including rights to receive payment in cash or securities based on the value, rate or price of one or more specified commodities, currencies, securities or indices, or any combination of the foregoing, purchasable upon exercise of such warrants;

    the price at which and the currency or currencies in which the securities or other rights purchasable upon exercise of such warrants may be purchased;

    the date on which the right to exercise such warrants shall commence and the date on which such right shall expire;

    if applicable, the minimum or maximum amount of such warrants which may be exercised at any one time;

    if applicable, the designation and terms of the securities with which such warrants are issued and the number of such warrants issued with each such security;

    if applicable, the date on and after which such warrants and the related securities will be separately transferable;

    information with respect to book-entry procedures, if any;

    if applicable, a discussion of any material United States federal income tax considerations; and

    any other terms of such warrants, including terms, procedures and limitations relating to the exchange and exercise of such warrants.

22


Table of Contents


DESCRIPTION OF UNITS

        As specified in the applicable prospectus supplement, we may issue units consisting of one or more warrants, debt securities, shares of common stock or any combination of such securities. The applicable prospectus supplement will describe:

    the terms of the units and of the warrants, debt securities and common stock comprising the units, including whether and under what circumstances the securities comprising the units may be traded separately;

    a description of the terms of any unit agreement governing the units; and

    a description of the provisions for the payment, settlement, transfer or exchange of the units.

23


Table of Contents


FORMS OF SECURITIES

        Each debt security, warrant, and unit will be represented either by a certificate issued in definitive form to a particular investor or by one or more global securities representing the entire issuance of securities. Certificated securities will be issued in definitive form and global securities will be issued in registered form. Definitive securities name you or your nominee as the owner of the security, and in order to transfer or exchange these securities or to receive payments other than interest or other interim payments, you or your nominee must physically deliver the securities to the trustee, registrar, paying agent or other agent, as applicable. Global securities name a depositary or its nominee as the owner of the debt securities, warrants, or units represented by these global securities. The depositary maintains a computerized system that will reflect each investor's beneficial ownership of the securities through an account maintained by the investor with its broker/dealer, bank, trust company or other representative, as we explain more fully below.

Global Securities

        Registered Global Securities.    We may issue the registered debt securities, warrants, and units in the form of one or more fully registered global securities that will be deposited with a depositary or its nominee identified in the applicable prospectus supplement and registered in the name of that depositary or nominee. In those cases, one or more registered global securities will be issued in a denomination or aggregate denominations equal to the portion of the aggregate principal or face amount of the securities to be represented by registered global securities. Unless and until it is exchanged in whole for securities in definitive registered form, a registered global security may not be transferred except as a whole by and among the depositary for the registered global security, the nominees of the depositary or any successors of the depositary or those nominees.

        If not described below, any specific terms of the depositary arrangement with respect to any securities to be represented by a registered global security will be described in the prospectus supplement relating to those securities. We anticipate that the following provisions will apply to all depositary arrangements.

        Ownership of beneficial interests in a registered global security will be limited to persons, called participants, that have accounts with the depositary or persons that may hold interests through participants. Upon the issuance of a registered global security, the depositary will credit, on its book-entry registration and transfer system, the participants' accounts with the respective principal or face amounts of the securities beneficially owned by the participants. Any dealers, underwriters or agents participating in the distribution of the securities will designate the accounts to be credited. Ownership of beneficial interests in a registered global security will be shown on, and the transfer of ownership interests will be effected only through, records maintained by the depositary, with respect to interests of participants, and on the records of participants, with respect to interests of persons holding through participants. The laws of some states may require that some purchasers of securities take physical delivery of these securities in definitive form. These laws may impair your ability to own, transfer or pledge beneficial interests in registered global securities.

        So long as the depositary, or its nominee, is the registered owner of a registered global security, that depositary or its nominee, as the case may be, will be considered the sole owner or holder of the securities represented by the registered global security for all purposes under the applicable indenture, warrant agreement or unit agreement. Except as described below, owners of beneficial interests in a registered global security will not be entitled to have the securities represented by the registered global security registered in their names, will not receive or be entitled to receive physical delivery of the securities in definitive form and will not be considered the owners or holders of the securities under the applicable indenture, warrant agreement or unit agreement. Accordingly, each person owning a beneficial interest in a registered global security must rely on the procedures of the depositary for that

24


Table of Contents

registered global security and, if that person is not a participant, on the procedures of the participant through which the person owns its interest, to exercise any rights of a holder under the applicable indenture, warrant agreement or unit agreement. We understand that under existing industry practices, if we request any action of holders or if an owner of a beneficial interest in a registered global security desires to give or take any action that a holder is entitled to give or take under the applicable indenture, warrant agreement or unit agreement, the depositary for the registered global security would authorize the participants holding the relevant beneficial interests to give or take that action, and the participants would authorize beneficial owners owning through them to give or take that action or would otherwise act upon the instructions of beneficial owners holding through them.

        Principal, premium, if any, and interest payments on debt securities, and any payments to holders with respect to warrants or units, represented by a registered global security registered in the name of a depositary or its nominee will be made to the depositary or its nominee, as the case may be, as the registered owner of the registered global security. None of PepsiCo, the trustee, the warrant agents, the unit agents or any other agent of PepsiCo, agent of the trustee or agent of the warrant agents or unit agents will have any responsibility or liability for any aspect of the records relating to payments made on account of beneficial ownership interests in the registered global security or for maintaining, supervising or reviewing any records relating to those beneficial ownership interests.

        We expect that the depositary for any of the securities represented by a registered global security, upon receipt of any payment of principal, premium, interest or other distribution of underlying securities or other property to holders on that registered global security, will immediately credit participants' accounts in amounts proportionate to their respective beneficial interests in that registered global security as shown on the records of the depositary. We also expect that payments by participants to owners of beneficial interests in a registered global security held through participants will be governed by standing customer instructions and customary practices, as is now the case with the securities held for the accounts of customers in bearer form or registered in "street name," and will be the responsibility of those participants.

        If the depositary for any of these securities represented by a registered global security is at any time unwilling or unable to continue as depositary or ceases to be a clearing agency registered under the Exchange Act, and a successor depositary registered as a clearing agency under the Exchange Act is not appointed by us within 90 days, we will issue securities in definitive form in exchange for the registered global security that had been held by the depositary. Any securities issued in definitive form in exchange for a registered global security will be registered in the name or names that the depositary gives to the relevant trustee, warrant agent, unit agent or other relevant agent of ours or theirs. It is expected that the depositary's instructions will be based upon directions received by the depositary from participants with respect to ownership of beneficial interests in the registered global security that had been held by the depositary.

25


Table of Contents


VALIDITY OF SECURITIES

        The validity of the securities in respect of which this prospectus is being delivered will be passed on for us by Davis Polk & Wardwell LLP, New York, New York, as to New York law, and by Womble Bond Dickinson (US) LLP, Research Triangle Park, North Carolina, as to North Carolina law.


EXPERTS

        The consolidated financial statements of PepsiCo, Inc. as of December 29, 2018 and December 30, 2017, and for each of the fiscal years in the three-year period ended December 29, 2018, and management's assessment of the effectiveness of internal control over financial reporting as of December 29, 2018, are incorporated by reference herein in reliance upon the reports of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

        KPMG's report on the effectiveness of internal control over financial reporting as of December 29, 2018 contains an explanatory paragraph that states the scope of management's assessment of the effectiveness of internal control over financial reporting excluded the internal control over financial reporting of SodaStream International Ltd. and its subsidiaries ("SodaStream"), which the Company acquired in December 2018. SodaStream's total assets and net revenue represented approximately 5% and 1%, respectively, of the consolidated total assets and net revenue of PepsiCo, Inc. as of and for the year ended December 29, 2018. KPMG's audit of internal control over financial reporting of PepsiCo, Inc. also excluded an evaluation of the internal control over financial reporting of SodaStream.

        With respect to the unaudited interim financial information for the 12 weeks ended March 23, 2019 and March 24, 2018, the 12 and 24 weeks ended June 15, 2019 and June 16, 2018, and the 12 and 36 weeks ended September 7, 2019 and September 8, 2018, incorporated by reference herein, the independent registered public accounting firm has reported that they applied limited procedures in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) for a review of such information. However, their separate reports included in the Company's quarterly reports on Form 10-Q for the quarters ended March 23, 2019, June 15, 2019 and September 7, 2019, and incorporated by reference herein, state that they did not audit and they do not express an opinion on that interim financial information. Accordingly, the degree of reliance on their reports on such information should be restricted in light of the limited nature of the review procedures applied. The accountants are not subject to the liability provisions of Section 11 of the Securities Act of 1933 for their reports on the unaudited interim financial information because those reports are not a "report" or a "part" of the registration statement prepared or certified by the accountants within the meaning of Sections 7 and 11 of the Securities Act of 1933.

26


Table of Contents


PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.    Other Expenses of Issuance and Distribution

        The following table sets forth the costs and expenses payable by the registrant in connection with the sale of the securities being registered hereby.

 
  Amount to be Paid  

Registration fee

                      

Printing

                       *

Legal fees and expenses

                       *

Trustee fees

                       *

Accounting fees and expenses

                       *

Miscellaneous

                       *

Total

                       *

Deferred in reliance upon Rule 456(b) and Rule 457(r).

*
Not presently determinable.

Item 15.    Indemnification of Directors and Officers

        PepsiCo, Inc. ("PepsiCo") does not have any provisions for indemnification of directors or officers in its Amended and Restated Articles of Incorporation. Article III, Section 3.7 of the By-Laws, as amended and restated, effective as of January 11, 2016, provides that unless the Board of Directors shall determine otherwise, PepsiCo shall indemnify, to the full extent permitted by law, any person who was or is, or who is threatened to be made, a party to an action, suit or proceeding (and any appeal therein), whether civil, criminal, administrative, investigative or arbitrative, by reason of the fact that such person, such person's testator or intestate, is or was a director, officer or employee of PepsiCo, or is or was serving at the request of PepsiCo as a director, officer or employee of another enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding. At the Board's discretion, such indemnification may also include advances of a director's, officer's or employee's expenses prior to final disposition of such action, suit or proceeding.

        Section 55-2-02 of the North Carolina Business Corporation Act (the "North Carolina Act") enables a corporation in its articles of incorporation to eliminate or limit, with certain exceptions, the personal liability of directors arising out of an action whether by or in the right of the corporation or otherwise for monetary damages for breach of their duties as directors. No such provision is effective to eliminate or limit a director's liability for: (1) acts or omissions that the director at the time of the breach knew or believed to be clearly in conflict with the best interests of the corporation; (2) improper distributions as described in Section 55-8-33 of the North Carolina Act; (3) any transaction from which the director derived an improper personal benefit; or (4) acts or omissions occurring prior to the date the exculpatory provision became effective. As noted above, PepsiCo's Amended and Restated Articles of Incorporation do not contain a provision that eliminates or limits such personal liability.

        Sections 55-8-50 through 55-8-58 of the North Carolina Act permit a corporation to indemnify its directors, officers, employees or agents under either or both a statutory or nonstatutory scheme of indemnification. Under the statutory scheme, a corporation may, with certain exceptions, indemnify a director, officer, employee or agent of the corporation who was, is, or is threatened to be made, a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal,

II-1


Table of Contents

administrative, or investigative and whether formal or informal, because of the fact that such person was or is a director, officer, agent or employee of the corporation, or is or was serving at the request of such corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan, or other enterprise. This indemnity may include the obligation to pay any judgment, settlement, penalty, fine (including an excise tax assessed with respect to an employee benefit plan) or reasonable expenses incurred in connection with a proceeding (including counsel fees), but no such indemnification may be granted unless such director, officer, employee or agent (1) conducted himself in good faith, (2) reasonably believed (a) that any action taken in his official capacity with the corporation was in the best interests of the corporation or (b) that in all other cases his conduct was at least not opposed to the corporation's best interests, and (3) in the case of any criminal proceeding, had no reasonable cause to believe his conduct was unlawful. Whether a director has met the requisite standard of conduct for the type of indemnification set forth above is determined by a majority vote of a quorum of the board of directors who are not parties to the proceeding in question, a duly designated committee of directors if a quorum of the full board cannot be established, special legal counsel selected by the board or duly designated committee of directors, or the shareholders (excluding shares owned or controlled by directors who are parties to the proceeding in question) in accordance with Section 55-8-55 of the North Carolina Act. A corporation may not indemnify a director under the statutory scheme in connection with a proceeding by or in the right of the corporation in which a director was adjudged liable to the corporation or in connection with any other proceeding charging improper personal benefit in which a director was adjudged liable (whether or not involving action in his official capacity) on the basis of having received an improper personal benefit.

        Sections 55-8-52 and 55-8-56 of the North Carolina Act require a corporation, unless its articles of incorporation provide otherwise, to indemnify a director or officer who has been wholly successful, on the merits or otherwise, in the defense of any proceeding to which such director or officer was, or was threatened to be, made a party because he is or was a director or officer of the corporation against reasonable expenses incurred by him in connection with the proceeding. Unless prohibited by the articles of incorporation, a director or officer also may make application for and obtain court-ordered indemnification if the court determines that such director or officer is (1) entitled to mandatory indemnification under Section 55-8-52, in which case the court will also order the corporation to pay the director's or officer's reasonable expenses incurred to obtain court-ordered indemnification, and (2) fairly and reasonably entitled to indemnification in view of all relevant circumstances, whether or not he met the standard of conduct set forth in Section 55-8-51 or was adjudged liable as described in Section 55-8-51.

        In addition to, and notwithstanding the conditions of and limitations on, the indemnification described above under the statutory scheme, Section 55-8-57 of the North Carolina Act permits a corporation to indemnify, or agree to indemnify, any of its directors, officers, employees or agents against liability and expenses (including attorneys' fees) in any proceeding (including proceedings brought by or on behalf of the corporation) arising out of their status as such or their activities in such capacities, except for any liabilities or expenses incurred on account of activities that were, at the time taken, known or believed by the person to be clearly in conflict with the best interests of the corporation. Consistent with the foregoing, PepsiCo has entered into indemnification agreements with each of its independent directors, pursuant to which PepsiCo has agreed to indemnify and hold harmless, to the full extent permitted by law, each director against any and all liabilities and assessments (including attorneys' fees and other costs, expenses and obligations) arising out of or related to any threatened, pending or completed action, suit, proceeding, inquiry or investigation, whether civil, criminal, administrative, or other, including, but not limited to, judgments, fines, penalties and amounts paid in settlement (whether with or without court approval), and any interest, assessments, excise taxes or other charges paid or payable in connection with or in respect of any of the foregoing, incurred by the independent director and arising out of his status as a director or member of

II-2


Table of Contents

a committee of the Board of PepsiCo, or by reason of anything done or not done by the director in such capacities. After receipt of an appropriate request by an independent director, PepsiCo will also advance all expenses, costs and other obligations (including attorneys' fees) arising out of or related to such matters. PepsiCo will not be liable for payment of any liability or expense incurred by an independent director on account of acts which, at the time taken, were known or believed by such director to be clearly in conflict with PepsiCo's best interests.

        Additionally, Section 55-8-57 of the North Carolina Act authorizes a corporation to purchase and maintain insurance on behalf of an individual who is or was a director, officer, employee or agent of the corporation against certain liabilities incurred by such a person, whether or not the corporation is otherwise authorized by the North Carolina Act to indemnify that person. PepsiCo has purchased and maintains such insurance.

        The PepsiCo, Inc. Underwriting Agreement Standard Provisions dated as of November 18, 2019 included as Exhibit 1.2 to this registration statement provides for indemnification of directors and officers of the registrant by the underwriters against certain liabilities.

Item 16.    Exhibits

        (a)   The list of exhibits is incorporated herein by reference to the Exhibit Index following the signature pages.

Item 17.    Undertakings

        (a)   The undersigned registrant hereby undertakes:

            (1)   To file, during any period in which offers or sales are being made of securities registered hereby, a post-effective amendment to this registration statement:

                (i)  to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

               (ii)  to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement;

              (iii)  to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

    provided, however, that paragraphs (i), (ii) and (iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

II-3


Table of Contents

            (2)   That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

            (3)   To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

            (4)   That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

              (A)  Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

              (B)  Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

            (5)   That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:

              The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

                  (i)  Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

                 (ii)  Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

                (iii)  The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

                (iv)  Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

II-4


Table of Contents

        (b)   The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

        (c)   Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

        (d)   The undersigned registrant hereby undertakes that:

            (1)   For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective; and

            (2)   For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

II-5


Table of Contents

SIGNATURES

        Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Purchase, State of New York, on November 18, 2019.

    PEPSICO, INC.

 

 

By:

 

/s/ RAMON L. LAGUARTA

        Name:   Ramon L. Laguarta
        Title:   Chairman of the Board of Directors and Chief Executive Officer

        KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Yawman, Cynthia Nastanski and Heather A. Hammond, and each of them severally, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and any and all additional registration statements pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.

        Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature
 
Title
 
Date

 

 

 

 

 
/s/ RAMON L. LAGUARTA

Ramon L. Laguarta
  Chairman of the Board of Directors and Chief Executive Officer   November 18, 2019

/s/ HUGH F. JOHNSTON

Hugh F. Johnston

 

Vice Chairman, Executive Vice President and Chief Financial Officer

 

November 18, 2019

/s/ MARIE T. GALLAGHER

Marie T. Gallagher

 

Senior Vice President and Controller (principal accounting officer)

 

November 18, 2019

/s/ SHONA L. BROWN

Shona L. Brown

 

Director

 

November 18, 2019

II-6


Table of Contents

Signature
 
Title
 
Date

 

 

 

 

 
/s/ CESAR CONDE

Cesar Conde
  Director   November 18, 2019

/s/ IAN M. COOK

Ian M. Cook

 

Director

 

November 18, 2019

/s/ DINA DUBLON

Dina Dublon

 

Director

 

November 18, 2019

/s/ RICHARD W. FISHER

Richard W. Fisher

 

Director

 

November 18, 2019

/s/ MICHELLE GASS

Michelle Gass

 

Director

 

November 18, 2019

/s/ WILLIAM R. JOHNSON

William R. Johnson

 

Director

 

November 18, 2019

/s/ DAVID C. PAGE

David C. Page

 

Director

 

November 18, 2019

/s/ ROBERT C. POHLAD

Robert C. Pohlad

 

Director

 

November 18, 2019

/s/ DANIEL VASELLA

Daniel Vasella

 

Director

 

November 18, 2019

/s/ DARREN WALKER

Darren Walker

 

Director

 

November 18, 2019

/s/ ALBERTO WEISSER

Alberto Weisser

 

Director

 

November 18, 2019

II-7


Table of Contents


EXHIBIT INDEX

Exhibit
No.
  Document
  1.1   Form of terms agreement (debt securities)

 

1.2

 

PepsiCo, Inc. Underwriting Agreement Standard Provisions dated as of November 18, 2019

 

1.3

*

Underwriting agreement (common stock)

 

1.4

 

Form of distribution agreement (debt securities, warrants and units) (incorporated herein by reference to exhibit 1.2 to the registrant's registration statement on Form S-3 (File No. 333-177307) filed on October 13, 2011)

 

4.1

 

Articles of Incorporation of PepsiCo, Inc., as amended and restated, effective as of May 1, 2019 (incorporated herein by reference to exhibit 3.1 to the registrant's current report on Form 8-K filed on May 3, 2019)

 

4.2

 

By-Laws of PepsiCo, Inc., as amended and restated, effective as of January 11, 2016 (incorporated herein by reference to exhibit 3.2 to the registrant's current report on Form 8-K filed on January 11, 2016)

 

4.3

 

Indenture dated as of May 21, 2007, between PepsiCo, Inc. and The Bank of New York, as trustee (incorporated herein by reference to exhibit 4.3 to the registrant's registration statement on Form S-3 (File No. 333-154314) filed on October 15, 2008)

 

4.4

 

Form of note (included in exhibit 4.3; forms for individual issuances of offered securities to be filed by amendment or as an exhibit to a document to be incorporated by reference herein in connection with the offering of such offered securities)

 

4.5

*

Form of warrant agreement

 

4.6

*

Form of unit agreement

 

4.7

 

Board of Directors Resolutions Authorizing PepsiCo, Inc.'s Officers to Establish the Terms of the Notes (incorporated herein by reference to exhibit 4.4 to the registrant's current report on Form 8-K filed on February 28, 2013)

 

5.1

 

Opinion of Davis Polk & Wardwell LLP

 

5.2

 

Opinion of Womble Bond Dickinson (US) LLP

 

15.1

 

Letter regarding unaudited interim financial information

 

23.1

 

Consent of KPMG LLP

 

23.2

 

Consent of Davis Polk & Wardwell LLP (included in exhibit 5.1)

 

23.3

 

Consent of Womble Bond Dickinson (US) LLP (included in exhibit 5.2)

 

24.1

 

Power of attorney (included on the signature page of this registration statement)

 

25.1

 

Statement of eligibility on Form T-1 of The Bank of New York Mellon with respect to the Indenture dated as of May 21, 2007

*
To be filed by amendment or as an exhibit to a document to be incorporated by reference herein in connection with an offering of the offered securities.

II-8



EX-1.1 2 a2240066zex-1_1.htm EX-1.1

Exhibit 1.1

 

PEPSICO, INC.

 

[IDENTIFY UNDERWRITTEN SECURITIES]

 

TERMS AGREEMENT

 

[date]

 

To:                             PepsiCo, Inc.
700 Anderson Hill Road
Purchase, New York 10577

 

Ladies and Gentlemen:

 

We understand that PepsiCo, Inc., a North Carolina corporation (the “Company”), proposes to issue and sell [identify Underwritten Securities] (the “Underwritten Securities”) subject to the terms and conditions stated herein and in the PepsiCo, Inc. Underwriting Agreement Standard Provisions dated as of November 18, 2019 and attached as Exhibit 1.2 to the Company’s Registration Statement on Form S-3 (File No. 333-[file number] (the “Standard Provisions”). Each of the applicable provisions in the Standard Provisions (including defined terms) is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein. We, the underwriters named below (the “Underwriters”), offer to purchase, severally and not jointly, the amount of Underwritten Securities opposite our names set forth below at a purchase price equal to [insert purchase price(s) for Underwritten Securities].

 

 

 

Principal Amount of

 

Underwriters

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

 

The Underwriters agree to reimburse the Company for $[insert reimbursement amount] of its expenses incurred in connection with the offering of the Underwritten Securities; such reimbursement to occur simultaneously with the purchase and sale of the Underwritten Securities at the Closing Time.

 

[Section 9(a)(vii) of the Standard Provisions shall apply to the Underwritten Securities.]

 

[Section 9(c), (d) and (e) of the Standard Provisions shall apply to this Agreement. The Stabilizing Manager is [Underwriter]. The Manufacturers are [Underwriter], [Underwriter] and [Underwriter].]

 

[Section 9(f) of the Standard Provisions shall apply to this Agreement.]

 

For purposes of Section 21 of the Standard Provisions, the identified provisions are: [(i) the fifth paragraph of text under the caption “Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus; (ii) the third sentence of the seventh paragraph of text under the caption “Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus; (iii) the eighth paragraph of text under the caption “Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus; and (iv) the tenth and eleventh paragraphs of text under the caption

 


 

“Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus]. [update as necessary]

 

[Add any additional agreed terms.]

 

[The undersigned are acting as the “Representative” under the Standard Provisions (the “Representatives”). The Representatives represent and warrant that they are duly authorized to execute and deliver this Terms Agreement on behalf of the several Underwriters named above.]

 

The Underwritten Securities and the offering thereof shall have the following additional terms: [update as necessary]

 

Issuer:

 

PepsiCo, Inc.

Trade Date:

 

 

Time of Sale:

 

[time of sale] on the Trade Date

Settlement Date (T+[2]):

 

 

Closing Time:

 

[closing time] on the Settlement Date

Closing Location:

 

 

Time of Sale Prospectus:

 

Base prospectus dated November 18, 2019, preliminary prospectus supplement dated [pricing date] and free writing prospectus dated [pricing date]

Title of Securities:

 

 

 

 

 

 

 

 

 

 

Aggregate Principal Amount Offered:

 

 

 

 

 

 

 

 

 

 

Maturity Date:

 

 

 

 

 

 

 

 

 

 

Interest Payment Dates:

 

 

 

 

 

 

 

 

 

 

Spread to LIBOR:

 

 

 

 

 

 

 

 

 

 

Designated LIBOR Page:

 

 

 

 

 

 

 

 

 

 

Index Maturity:

 

 

 

 

 

 

 

 

 

 

Interest Reset Dates:

 

 

 

 

 

 

 

 

 

 

Initial Interest Rate:

 

 

 

 

 

 

 

 

 

 

Benchmark Treasury:

 

 

 

 

 

 

 

 

 

 

Benchmark Treasury Yield:

 

 

 

 

 

 

 

 

 

 

Spread to Treasury:

 

 

 

 

 

 

 

 

 

 

Re-offer Yield:

 

 

 

 

 

 

 

 

 

 

Coupon:

 

 

 

 

 

 

 

 

 

 

Price to Public:

 

 

 

 

 

 

 

 

 

 

Optional Redemption:

 

 

 

 

 

 

 

 

 

 

Net Proceeds to PepsiCo (Before Expenses):

 

 

 

 

 

 

 

 

 

 

Use of Proceeds:

 

 

 

 

 

 

 

 

 

 

Day Count Fraction:

 

 

 

 

 

 

 

 

 

 

CUSIP / ISIN:

 

 

 

 

 

 

 

 

 

 

Minimum Denomination:

 

 

 

 

 

 

 

 

 

 

 

2


 

Joint Book-Running Managers:

 

 

 

 

 

 

 

 

 

 

Co-Managers:

 

 

 

 

 

 

 

 

 

 

Address, Facsimile Number and Email Address for Notices to the Representatives:

 

 

 

 

 

 

 

 

 

 

 

3


 

IN WITNESS WHEREOF, the parties hereto have executed this Terms Agreement as of the date first above written.

 

 

PEPSICO, INC.

 

 

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

CONFIRMED AND ACCEPTED, as of the date first above written:

 

[NAMES OF REPRESENTATIVES]

 

[as Representatives of the several Underwriters]

 

By:

[REPRESENTATIVE]

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

Title:

 

 

By:

[REPRESENTATIVE]

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

Title:

 

 

By:

[REPRESENTATIVE]

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

Title:

 

 

4


 

Schedule I

 

Time of Sale Prospectus:

 

1.                       Preliminary Prospectus dated [pricing date] (including the Base Prospectus dated November 18, 2019)

 

2.                       Any free writing prospectuses approved by the Representatives and filed by the Company under Rule 433(d) under the Securities Act

 

3.                       Final Term Sheet dated [pricing date] to be filed by the Company pursuant to Rule 433 under the Securities Act setting forth certain terms of the Underwritten Securities

 



EX-1.2 3 a2240066zex-1_2.htm EX-1.2

Exhibit 1.2

 

PEPSICO, INC.

 

Underwritten Securities
(Debt Securities)

 

UNDERWRITING AGREEMENT STANDARD PROVISIONS

 

As of November 18, 2019

 

From time to time, PepsiCo, Inc., a corporation organized under the laws of the State of North Carolina (the “Company”), may enter into one or more terms agreements (each, a “Terms Agreement”) in substantially the form of Exhibit A hereto, with such additions and deletions as the parties thereto may determine, and, subject to the terms and conditions stated herein and therein, to issue and sell certain debt securities (the “Securities”) to the underwriter or underwriters named in the applicable Terms Agreement (the “Underwriters,” which term shall include any underwriter substituted pursuant to Section 8 hereof). The provisions included herein (the “Standard Provisions”) shall be incorporated by reference into each Terms Agreement.

 

Section 1. Definitions. The Company has filed with the Securities and Exchange Commission (the “Commission”) an “automatic shelf registration statement” as defined in Rule 405 under the Securities Act of 1933, as amended (the “Securities Act”) on Form S-3 covering the registration of certain Securities of the Company to be issued and sold from time to time, in or pursuant to one or more offerings on terms to be determined at the time of sale, in accordance with Rule 415 under the Securities Act. Such registration statement (as so amended, if applicable), including the information, if any, deemed to be a part thereof pursuant to Rule 430B under the Securities Act (the “Rule 430 Information”), is referred to herein as the “Registration Statement”; and the base prospectus included in the Registration Statement at the time of filing (the “Base Prospectus”) and the final prospectus supplement relating to a particular offering of Underwritten Securities (as defined below) referred to in a Terms Agreement, in the forms first used to confirm sales of such Underwritten Securities (or in the form first made available to the Underwriters by the Company to meet requests of purchasers pursuant to Rule 173 under the Securities Act), are collectively referred to herein as the “Prospectus.” All references herein to the “Registration Statement” and the “Prospectus” shall be deemed to include all documents incorporated therein by reference which are filed by the Company pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or the Securities Act, prior to the execution of the applicable Terms Agreement. References herein to a “preliminary prospectus” relating to an offering of particular Underwritten Securities pursuant to a Terms Agreement shall be deemed to refer to the Base Prospectus and to the prospectus supplement (a “preliminary prospectus supplement”) relating to such Underwritten Securities that omitted Rule 430 Information or other information to be included upon pricing in a form of prospectus relating to such Underwritten Securities filed by the Company with the Commission pursuant to Rule 424(b) under the Securities Act and that was used prior to the initial delivery of the Prospectus relating to such Underwritten Securities to the Underwriters by the Company.

 

For purposes of these Standard Provisions and the Terms Agreement relating to an offering of particular Underwritten Securities, “free writing prospectus” has the meaning set forth in Rule 405 under the Securities Act, and “Time of Sale Prospectus” means the Base Prospectus, the final preliminary prospectus supplement filed prior to the “Time of Sale” set forth in such Terms Agreement, together with any free writing prospectus or other information stated in such Terms Agreement to form part of the Time of Sale Prospectus. For purposes of these Standard Provisions, all references to the “Registration Statement,” “Prospectus,” “preliminary prospectus” or “Time of Sale Prospectus” or to any amendment or supplement to any of the foregoing shall be deemed to include any copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval system (“EDGAR”).

 

All references in these Standard Provisions to financial statements and schedules and other information which is “contained,” “included” or “stated” (or other references of like import) in the Registration Statement, preliminary prospectus, Time of Sale Prospectus or Prospectus shall be deemed to mean and include all such financial statements and schedules and other information which is incorporated by reference in the Registration Statement, the applicable preliminary prospectus, the applicable Time of Sale Prospectus or the applicable Prospectus, as the case may be,

 


 

prior to the execution of the applicable Terms Agreement; and all references in these Standard Provisions to amendments or supplements to the Registration Statement, preliminary prospectus, Time of Sale Prospectus or Prospectus shall be deemed to include the filing of any document or portion of a document under the Exchange Act which is incorporated by reference in the Registration Statement, the applicable preliminary prospectus, the applicable Time of Sale Prospectus or the applicable Prospectus, as the case may be, after the execution of the applicable Terms Agreement.

 

Section 2. Purchase and Sale of Securities by the Underwriters. Whenever the Company determines to make an offering of Securities to be governed by these Standard Provisions, the Company will enter into a Terms Agreement providing for the sale of such Securities to, and the purchase and offering thereof by, the Underwriters. The Terms Agreement relating to the offering of Securities shall specify the number or amount of Securities to be issued (the “Underwritten Securities”), the name of each Underwriter participating in such offering (subject to substitution as provided in Section 8 hereof) and the name of any Underwriter acting as manager or co-manager in connection with such offering, the number or amount of Underwritten Securities which each such Underwriter severally agrees to purchase, whether such offering is on a fixed or variable price basis and, if on a fixed price basis, the initial offering price, the price at which the Underwritten Securities are to be purchased by the Underwriters, the form, time, date and place of delivery and payment of the Underwritten Securities and any other material terms of the Underwritten Securities. The Terms Agreement may take the form of an exchange of any standard form of written telecommunication between the Company and the Underwriter or Underwriters, acting through the Underwriters’ representative (the “Representative”) identified as such in the applicable Terms Agreement. Each offering of Underwritten Securities will be governed by these Standard Provisions, as supplemented by the applicable Terms Agreement.

 

As used herein, “Business Day” means (i) unless clause (ii) is applicable, any day other than a Saturday, Sunday or other day on which commercial banks are permitted or required to be closed in New York City and (ii) in the event the Underwritten Securities are denominated in euro, any day, other than a Saturday or Sunday, (1) which is not a day on which banking institutions in the City of New York or the City of London are authorized or required by law or executive order to close and (2) on which the Trans-European Automated Real-time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, operates.

 

Section 3. Underwriters’ Obligation to Purchase Underwritten Securities. The several commitments of the Underwriters to purchase the Underwritten Securities pursuant to the applicable Terms Agreement shall be deemed to have been made on the basis of the representations, warranties and agreements herein contained and shall be subject to the terms and conditions herein set forth.

 

Section 4. Terms Agreement. No agreement for the purchase of the Underwritten Securities by the Underwriters will be deemed to exist until the Company and the Representative, on behalf of the Underwriters, have executed a Terms Agreement. Each Terms Agreement will incorporate all applicable terms and provisions of these Standard Provisions as fully as though such terms and provisions were expressly stated therein.

 

Section 5. Delivery of Certain Documents, Certificates, and Opinions. At each Closing Time (as defined below), the Underwriters shall have received the following documents:

 

(a) the opinion and disclosure letter of Davis Polk & Wardwell LLP, or other special New York counsel for the Company reasonably acceptable to the Representative; the opinion of internal counsel for the Company; and the opinion of Womble Bond Dickinson (US) LLP, or other special North Carolina counsel for the Company reasonably acceptable to the Representative, each dated as of the Closing Date, substantially in the respective forms of Exhibits B-1, B-2, B-3 and B-4 hereto,

 

(b) the opinion of counsel to the Underwriters, selected by the Representative and reasonably acceptable to the Company, dated as of the Closing Date, in form and substance reasonably satisfactory to the Underwriters,

 

(c) a certificate of the Assistant Secretary of the Company, dated as of the Closing Date, substantially in the form of Exhibit C hereto, and

 

2


 

(d) a certificate of the Chief Financial Officer or Treasurer of the Company, dated as of the Closing Date, substantially in the form of Exhibit D hereto.

 

Section 6. Certain Conditions Precedent to the Underwriters’ Obligations. The Underwriters’ obligation to purchase any Underwritten Securities will in all cases be subject to (i) the accuracy of the representations and warranties of the Company set forth in Section 7 hereof, in each case at the time the Company executes a Terms Agreement, at the Time of Sale and as of the applicable Closing Date, (ii) the receipt of the opinions and certificates to be delivered to the Underwriters pursuant to the terms of Section 5 hereof, (iii) the accuracy of the statements of the Company’s officers made in each certificate to be furnished as provided herein, in each case at the applicable Closing Date, and (iv) the performance and observance by the Company of all covenants and agreements contained herein on its part to be performed and observed, and (in each case) to the following additional conditions precedent, when and as specified:

 

(a) As of the Closing Time for any Underwritten Securities, and with respect to the period from the date of the applicable Terms Agreement to and including the applicable Closing Time:

 

(i) there shall not have occurred (A) any material adverse change (or development involving a prospective material adverse change) in the business, properties, earnings, or financial condition of the Company and its subsidiaries on a consolidated basis (a “Material Adverse Effect”) or (B) any suspension or material limitation of trading in the Company’s common stock, par value one and two-thirds cents (1-2/3 cents) per share (the “Common Stock”), by the Commission or The Nasdaq Stock Market LLC (“Nasdaq”), the effect of any of which shall have made it impracticable, in the reasonable judgment of the Underwriters, to market such Underwritten Securities, such judgment to be based on relevant market conditions;

 

(ii) there shall not have occurred (A) any suspension or material limitation of trading in securities generally on Nasdaq, (B) a declaration of a general moratorium on commercial banking activities in New York by either Federal or New York State authorities, or (C) any outbreak or material escalation of hostilities or other national or international calamity or crisis, the effect of any of which shall have made it impracticable, in the judgment of the Underwriters, to market such Underwritten Securities, such judgment to be based on relevant market conditions; and

 

(iii) there shall not have been issued any stop order suspending the effectiveness of the Registration Statement nor shall any proceedings for that purpose or pursuant to Section 8A of the Securities Act against the Company or related to the offering of the Underwritten Securities have been instituted or threatened.

 

(b) The Underwriters will receive, upon execution and delivery of any applicable Terms Agreement, a letter from KPMG LLP, or such other independent registered public accounting firm as may be selected by the Company, containing statements and information of the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information of the Company contained in the Registration Statement, the final preliminary prospectus supplement and the Prospectus.

 

(c) At each Closing Time, the Underwriters shall have received from KPMG LLP, or such other independent registered public accounting firm as may be selected by the Company, a letter, dated as of the Closing Date, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (b) of this Section, except that the “cut off” date referred to therein shall be a date not more than five Business Days prior to the Closing Date.

 

(d) On each Closing Date, the Underwriters shall have received from the Company such appropriate further information, certificates, and documents as the Company and the Underwriters shall have agreed, as reflected in the applicable Terms Agreement.

 

(e) Subsequent to the execution and delivery of the applicable Terms Agreement and prior to the Closing Time, there shall not have been any material downgrading, nor any notice given of any intended or potential material downgrading or of a possible material change that does not indicate the direction of the possible material change, in the rating accorded any of the Company’s securities, including the Underwritten Securities, by either Moody’s Investors Service, Inc. or S&P Global Ratings.

 

3


 

Section 7. Representations and Warranties of the Company. The Company represents and warrants to each Underwriter named in the applicable Terms Agreement that, as of the date thereof, and as of each Closing Time, the following statements are and shall be true:

 

(a) (i) The Registration Statement constitutes an “automatic shelf registration statement” (as defined in Rule 405 under the Securities Act) filed within three years of the date of the applicable Terms Agreement, (ii) the Company is a “well known seasoned issuer” (as defined in Rule 405 under the Securities Act), (iii) the Company has not received from the Commission any notice pursuant to Rule 401(g)(2) under the Securities Act objecting to the use of the automatic shelf registration statement form, (iv) the Registration Statement became effective upon filing with the Commission and no stop order suspending the effectiveness of the Registration Statement is in effect nor, to the Company’s knowledge, are any proceedings for such purpose pending before or threatened by the Commission, (v) as of the effective date of the Registration Statement (the “Effective Date”), the Company met the applicable requirements for use of Form S-3 under the Securities Act with respect to the registration under the Securities Act of the Securities, and (vi) as of the Effective Date, the Registration Statement met the requirements set forth in Rule 415(a)(1)(x) under the Securities Act and complied in all material respects with said Rule.

 

(b) (i) Each document, if any, filed or to be filed pursuant to the Exchange Act or the Securities Act and incorporated or to be incorporated by reference in the Prospectus or Time of Sale Prospectus complies or will comply, in all material respects, with the applicable provisions of the Exchange Act or the Securities Act, as applicable, and the rules and regulations of the Commission thereunder, (ii) the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading, (iii) the Registration Statement and the Prospectus comply, in all material respects, with the Securities Act and the rules and regulations of the Commission thereunder, (iv) the Prospectus does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and (v) the Time of Sale Prospectus does not as of its date (which shall be the date of the preliminary prospectus supplement included therein, if applicable), and will not as of the Time of Sale and at the Closing Date, as then amended or supplemented by the Company, if applicable, contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Company makes no representations and warranties as to information contained in or omitted from the Registration Statement, the Prospectus or the Time of Sale Prospectus in reliance upon and in conformity with information furnished in writing to the Company by the Underwriters expressly for use in the Registration Statement, the Prospectus or the Time of Sale Prospectus or any amendment or supplement thereto or the Statement of Eligibility and Qualification of the Trustee (the “Form T-1”) under the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”).

 

(c) The Company is not an “ineligible issuer” in connection with the offering pursuant to Rules 164, 405 and 433 under the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder.

 

(d) The Company has been duly incorporated and is validly existing under the laws of the State of North Carolina, has the corporate power and authority to own its property and to conduct its business as described in the Time of Sale Prospectus and the Prospectus, and is duly qualified to transact business as a foreign corporation and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that the failure to be so qualified or in good standing would not have a Material Adverse Effect.

 

(e) The applicable Terms Agreement, incorporating these Standard Provisions as amended by agreement of the parties to the applicable Terms Agreement, as of the date of such Terms Agreement will have been duly authorized, executed and delivered by the Company.

 

(f) The Underwritten Securities have been duly authorized and, when issued, executed, and authenticated in accordance with the provisions of the applicable indenture (the “Indenture”), or when countersigned by the trustee in accordance with the provisions of the Indenture, as the case may be, will be entitled to the benefits of the Indenture, and will be valid and binding obligations of the Company, enforceable against the Company in

 

4


 

accordance with their respective terms, except as such enforceability may be limited by the laws of bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium, or similar laws relating to creditors’ rights generally, by any other federal or state laws, by rights of acceleration, if applicable, or by general principles of equity.

 

(g) The Indenture has been duly qualified under the Trust Indenture Act and has been duly authorized, executed, and delivered by the Company and (assuming due authorization, valid execution, and delivery thereof by the trustee) is a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by the laws of bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium, or similar laws relating to creditors’ rights generally, by any other federal or state laws, by rights of acceleration, or by general principles of equity.

 

(h) The execution and delivery of and performance by the Company of its obligations under the applicable Terms Agreement, incorporating these Standard Provisions as amended by agreement of the parties to such Terms Agreement and the Indenture and the issuance and sale of the Underwritten Securities, as the case may be, will not contravene any provision of any applicable law or of the Amended and Restated Articles of Incorporation or By-Laws of the Company, or of any agreement or other instrument binding upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries taken as a whole, or of any judgment, order, or decree of any governmental body, agency, or court having jurisdiction over the Company or any of its subsidiaries, in each of the foregoing cases except as would not reasonably be expected to have a Material Adverse Effect, and no consent, approval, authorization, or order of or qualification with any governmental body or agency is, to the Company’s knowledge, required for the performance by the Company of its obligations under the applicable Terms Agreement, incorporating these Standard Provisions as amended by agreement of the parties to such Terms Agreement, or the issuance and sale of the Underwritten Securities, except such as may be required by Blue Sky laws or other securities laws of the various states in which the issuance and sale of the Underwritten Securities are offered and sold and except to the extent where the failure to obtain such consent, approval, authorization, order or qualification would not reasonably be expected to have a Material Adverse Effect.

 

(i) There has not been any material adverse change (or development involving a prospective material adverse change) in the business, properties, earnings, or financial condition of the Company and its subsidiaries on a consolidated basis from that set forth in the Company’s last periodic report filed with the Commission under the Exchange Act and the rules and regulations promulgated thereunder. Since the respective dates as of which information is given in the Registration Statement, the Time of Sale Prospectus and the Prospectus, except as otherwise stated therein, there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock other than dividends declared, paid or made in the ordinary course.

 

(j) There are no legal or governmental proceedings pending or, to the Company’s knowledge, threatened, to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject that is required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus and is not so described, or any applicable statute, regulation, contract, or other document that is required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus that is not so described.

 

(k) The Company’s independent registered public accounting firm who audited the financial statements and supporting schedules of the Company incorporated by reference in the Registration Statement are independent registered public accountants as required by the Securities Act.

 

(l) The financial statements included or incorporated by reference in the Registration Statement, the Time of Sale Prospectus and the Prospectus, together with the related schedules and notes, present fairly the financial position of the Company and its consolidated subsidiaries at the dates indicated and the statement of operations, shareholders’ equity and cash flows of the Company and its consolidated subsidiaries for the periods specified; said financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“GAAP”) applied on a consistent basis throughout the periods involved. The supporting schedules, if any, present fairly in accordance with GAAP the information required to be stated therein. Any pro forma financial information and data included in the Registration Statement, the Time of Sale Prospectus and the Prospectus have been prepared in accordance with the requirements of Regulation S-X of the Securities Act, the assumptions used by management

 

5


 

in the preparation of such pro forma financial information and data are reasonable under the circumstances, the pro forma adjustments used therein are appropriate to give effect to the transactions or circumstances described therein and the pro forma adjustments have been properly applied to the historical amounts in the compilation of that information and data.

 

Section 8. Default by One or More of the Underwriters. If one or more of the Underwriters shall fail at the Closing Time to purchase the Underwritten Securities which it or they are obligated to purchase under the applicable Terms Agreement (the “Defaulted Securities”), then the remaining Underwriters shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Underwriters, or any other underwriters, to purchase all, but not less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Underwriters shall not have completed such arrangements within such 24-hour period, then:

 

(a) if the number or principal amount of Defaulted Securities does not exceed 10% of the number of Underwritten Securities to be purchased on such date pursuant to such Terms Agreement, the non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions that their respective underwriting obligations under such Terms Agreement bear to the underwriting obligations of all non-defaulting Underwriters, or

 

(b) if the number or aggregate principal amount of Defaulted Securities exceeds 10% of the number or aggregate principal amount of Underwritten Securities to be purchased on such date pursuant to such Terms Agreement, such Terms Agreement shall terminate without liability on the part of any non-defaulting Underwriter. No action taken pursuant to this Section 8 shall relieve any defaulting Underwriter from liability in respect of its default.

 

In the event of any such default which does not result in a termination of the applicable Terms Agreement, either the Underwriters or the Company shall have the right to postpone the Closing Time for a period not exceeding seven days in order to effect any required changes in the Registration Statement or the Prospectus or in any other documents or arrangements.

 

Section 9. Agreements.

 

(a) The Company covenants with the Underwriters as follows:

 

(i) Prior to the filing by the Company of any amendment to the Registration Statement, the Time of Sale Prospectus or of any prospectus supplement that shall name the Underwriters or the filing or use of any free writing prospectus, the Company will afford the Underwriters or their counsel a reasonable opportunity to review and comment on the same, provided, however, that the foregoing requirement will not apply to any of the Company’s filings with the Commission required to be filed pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act. Subject to the foregoing sentence, the Company will promptly cause each applicable prospectus supplement and free writing prospectus to be filed with or transmitted for filing with the Commission in accordance with Rule 424(b) or 424(c) under the Securities Act or Rule 433 under the Securities Act, respectively, or pursuant to such other rule or regulation of the Commission as then deemed appropriate by the Company. The Company will promptly advise the Underwriters of (A) the filing and effectiveness of any amendment to the Registration Statement other than by virtue of the Company’s filing any report required to be filed under the Exchange Act, (B) any request by the Commission for any amendment to the Registration Statement, for any amendment or supplement to the Time of Sale Prospectus or the Prospectus, or for any information from the Company, (C) the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or the institution or threatening of any proceeding for that purpose, and (D) the receipt by the Company of any notification with respect to the suspension of the qualification of the Underwritten Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose. The Company will use reasonable efforts to prevent the issuance of any such stop order or notice of suspension of qualification and, if issued, to obtain as soon as reasonably possible the withdrawal thereof.

 

6


 

(ii) If the Time of Sale Prospectus is being used to solicit offers to buy the Underwritten Securities at a time when the Prospectus is not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Prospectus in order to make the statements therein, in the light of the circumstances, not misleading, or if any event shall occur or condition exist as a result of which the Time of Sale Prospectus conflicts with the information contained in the Registration Statement then on file, or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as so amended or supplemented will not, in the light of the circumstances when delivered to a prospective purchaser, be misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the Registration Statement, or so that the Time of Sale Prospectus, as amended or supplemented, will comply with applicable law.

 

(iii) If, at any time when a Prospectus (or in lieu thereof the notice referred to in Rule 173(a) under the Securities Act) relating to any Underwritten Securities is required to be delivered under the Securities Act, any event occurs or condition exists as a result of which the Prospectus would include an untrue statement of a material fact, or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it is necessary to amend or supplement the Prospectus in order to comply with the Securities Act, the Exchange Act, the respective rules and regulations of the Commission thereunder, or any other applicable law, the Company will promptly notify the Underwriters by telephone, by electronic mail or by facsimile (in either case with written confirmation from the Company by mail), to cease use and distribution of the Prospectus (and all then existing supplements thereto) and to suspend all efforts to resell the Underwritten Securities in its capacity as underwriter or dealer, as the case may be, and the Underwriters will promptly comply with the terms of such notice. The Company will forthwith prepare and cause to be filed with the Commission an amendment or supplement to the Registration Statement or the Prospectus, as the case may be, satisfactory in the reasonable judgment of the Underwriters to correct such statement or omission or to effect such compliance, and the Company will supply the Underwriters with one signed copy of such amended Registration Statement and as many copies of such amended or supplemented Prospectus as the Underwriters may reasonably request, provided, however, that the expense of preparing, filing, and supplying copies to the Underwriters of any such amendment or supplement will be borne by the Company only for the nine-month period immediately following the purchase of such Underwritten Securities by the Underwriters and thereafter will be borne by the Underwriters.

 

(iv) The Company will furnish to the Underwriters, without charge, as many copies of the Time of Sale Prospectus, the Prospectus, each preliminary prospectus, any documents incorporated by reference therein, and any supplements and amendments thereto and any free writing prospectus as the Underwriters may reasonably request.

 

(v) The Company will, with such assistance from the Underwriters as the Company may reasonably request, endeavor to qualify the Securities for offer and sale under the Blue Sky laws or other securities laws of such jurisdictions as the Underwriters shall reasonably request and will maintain such qualifications for as long as required with respect to the offer, sale, and distribution of the Securities.

 

(vi) The Company will make generally available to its security holders earnings statements that satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 promulgated thereunder.

 

(vii) If the applicable Terms Agreement specifically provides that this Section 9(a)(vii) shall apply to the Underwritten Securities or any series thereof, the Company will use commercially reasonable efforts to cause the Underwritten Securities or the Underwritten Securities of such series, as applicable, to be listed for trading on the Nasdaq Bond Exchange within 30 days after the date of issuance of such Underwritten Securities.

 

7


 

(b) Each Underwriter, severally and not jointly, covenants with the Company as follows:

 

(i) It has not and will not use, authorize use of, refer to, or participate in the planning for use of, any “free writing prospectus,” as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) (each such communication by the Company or its agents or representatives (excluding any Underwriter) an “Issuer Free Writing Prospectus”) other than (A) a free writing prospectus that contains no “issuer information” (as defined in Rule 433(h)(2) under the Securities Act) that was not included (including through incorporation by reference) in the preliminary prospectus or a previously filed Issuer Free Writing Prospectus, (B) any Issuer Free Writing Prospectus listed on Schedule I to the applicable Terms Agreement or (C) any free writing prospectus prepared by such Underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (A) or (C), an “Underwriter Free Writing Prospectus”).

 

(ii) It has not and will not distribute any Underwriter Free Writing Prospectus referred to in Section 9(b)(i)(A) above in a manner reasonably designed to lead to its broad unrestricted dissemination.

 

(iii) It has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final terms of the Underwritten Securities unless such terms have previously been included in a free writing prospectus filed with the Commission.

 

(iv) It is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the “Prospectus Delivery Period”, which means such period of time beginning on the first date of the public offering of the Underwritten Securities and ending on the later of the Closing Date or such date, as in the opinion of counsel for the Underwriters a prospectus relating to the Underwritten Securities is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Underwritten Securities by any Underwriter or dealer).

 

(v) Notwithstanding any of the above, each of the Underwriters may use one or more term sheets relating to the Underwritten Securities containing customary information, including Bloomberg email announcement, price talk guidance, comparable bond pricing and final pricing terms, not inconsistent with the form of the final term sheet referred to in the Terms Agreement, without the prior consent of the Company, so long as such term sheet is not required to be filed as a “free writing prospectus” with the Commission pursuant to Rule 433 under the Securities Act.

 

(c) If the applicable Terms Agreement specifically provides that this Section 9(c) shall apply to such Terms Agreement, then the Company hereby authorizes the Stabilizing Manager named in such Terms Agreement in its role as stabilizing manager (the “Stabilizing Manager”) to make adequate public disclosure regarding stabilization of the information required in relation to such stabilization by Commission Regulation (EC) 2273/2003. The Stabilizing Manager for its own account may, to the extent permitted by applicable laws and directives, over-allot and effect transactions with a view to supporting the market price of the Underwritten Securities at a level higher than that which might otherwise prevail, but in doing so the Stabilizing Manager shall act as principal and not as agent of the Company and any loss resulting from over-allotment and stabilization shall be borne, and any profit arising therefrom shall be beneficially retained, by the Stabilizing Manager. However, there is no assurance that the Stabilizing Manager (or persons acting on behalf of the Stabilizing Manager) will undertake any stabilization action. Nothing contained in this paragraph (c) shall be construed so as to require the Company to issue in excess of the aggregate principal amount of Underwritten Securities specifically set forth in the applicable Terms Agreement. Such stabilization, if commenced, may be discontinued at any time and shall be conducted by the Stabilizing Manager in accordance with all applicable laws and directives.

 

(d) If the applicable Terms Agreement specifically provides that this Section 9(d) shall apply to such Terms Agreement, then notwithstanding any other term hereof or any other agreements, arrangements, or understanding between the Underwriters and the Company, the Company acknowledges, accepts, and agrees to be bound by (i) the effect of the exercise of Bail-in Powers by the Relevant Resolution Authority in relation to any BRRD Liability of an Underwriter to the Company under this Agreement, that (without limitation) may include and result in any of the

 

8


 

following, or some combination thereof: (A) the reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon; (B) the conversion of all, or a portion, of the BRRD Liability into shares, other securities or other obligations of the relevant Underwriter or another person (and the issue to or conferral on the Company of such shares, securities or obligations); (C) the cancellation of the BRRD Liability; (D) the amendment or alteration of any interest, if applicable, thereon, the maturity or the dates on which any payments are due, including by suspending payment for a temporary period; (ii) the variation of the terms of this Agreement, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of Bail-in Powers by the Relevant Resolution Authority. In the event any Underwriter has been notified by a Relevant Resolution Authority that it has become subject to the exercise of Bail-in Powers, such Underwriter shall promptly notify the Company.

 

As used in this Section 9(d), “Bail-in Legislation” means in relation to a member state of the European Economic Area which has implemented, or which at any time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU Bail-in Legislation Schedule from time to time; “Bail-in Powers” means any Write-down and Conversion Powers as defined in relation to the relevant Bail-in Legislation; “BRRD” means Directive 2014/59/EU establishing a framework for the recovery and resolution of credit institutions and investment firms; “EU Bail-in Legislation Schedule” means the document described as such, then in effect, and published by the Loan Market Association (or any successor person) from time to time at http://www.lma.eu.com/; “BRRD Liability” has the same meaning as in such laws, regulations, rules or requirements implementing the BRRD under the applicable Bail-in Legislation; and “Relevant Resolution Authority” means the resolution authority with the ability to exercise any Bail-in Powers in relation to the Underwriters.

 

(e) If the applicable Terms Agreement specifically provides that this Section 9(e) shall apply to such Terms Agreement, then solely for the purposes of the requirements of Article 9(8) of the MIFID Product Governance rules under EU Delegated Directive 2017/593 (the “Product Governance Rules”) regarding the mutual responsibilities of manufacturers under the Product Governance Rules:

 

(i) each of the Manufacturers named in such Terms Agreement acknowledges to each other Manufacturer that it understands the responsibilities conferred upon it under the Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Underwritten Securities and the related information set out in the Prospectus and announcements in connection with the Underwritten Securities; and

 

(ii) the other Underwriters note the application of the Product Governance Rules and acknowledge the target market and distribution channels identified as applying to the Underwritten Securities by the Manufacturers and the related information set out in the Prospectus and announcements in connection with the Underwritten Securities.

 

(f) If the applicable Terms Agreement specifically provides that this Section 9(f) shall apply to such Terms Agreement, then:

 

(i) In the event that any Underwriter is a Covered Entity that becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.

 

(ii) In the event that any Underwriter is a Covered Entity or a BHC Act Affiliate of any Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States.

 

For purposes of this Section 9(f), a “BHC Act Affiliate” has the meaning assigned to the term “affiliate” in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k). “Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R.

 

9


 

§ 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b). “Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable. “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.

 

Section 10. Fees and Expenses. Except as provided in the applicable Terms Agreement, the Company will pay all costs, fees, and expenses arising in connection with the sale of any Underwritten Securities through the Underwriters and in connection with the performance by the Company of its obligations hereunder and under any Terms Agreement, including the following: (i) expenses incident to the preparation and filing of the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company, and all amendments and supplements thereto, (ii) expenses incident to the issuance and delivery of such Underwritten Securities, (iii) the fees and disbursements of counsel for the Company and the Company’s independent registered public accounting firm, (iv) if approved by the Company in advance and in writing, expenses incident to the qualification of such Underwritten Securities under Blue Sky laws and other applicable state securities laws in accordance with the provisions of Section 9(a)(v) hereof, including related filing fees and the reasonable fees and disbursements of the Underwriters’ counsel in connection therewith and in connection with the preparation of any survey of Blue Sky laws, (v) expenses incident to the printing and delivery to the Underwriters, in the quantities hereinabove stated, of copies of the Registration Statement and all amendments thereto and of the Prospectus, each preliminary prospectus, and all amendments and supplements thereto, (vi) the fees and expenses, if any, incurred with respect to any applicable filing with the Financial Industry Regulatory Authority, (vii) the fees and expenses incurred in connection with the listing of any Underwritten Securities on Nasdaq and (viii) if applicable, the fees and expenses of the trustee under the applicable Indenture. If so stated in the applicable Terms Agreement, the Underwriters agree to reimburse the Company for the stated amount of its expenses incurred in connection with the transactions contemplated by the applicable Terms Agreement.

 

Section 11. Inspection; Place of Delivery; Payment.

 

(a) Inspection. The Company agrees to have available for inspection, checking, and packaging by the Underwriters in The City of New York, the Underwritten Securities to be sold to the Underwriters hereunder, not later than 1:00 P.M. on the Business Day prior to the applicable Closing Date.

 

(b) Place of Delivery of Documents, Certificates and Opinions. The documents, certificates and opinions required to be delivered to the Underwriters pursuant to Sections 5 and 6 hereof will be delivered at the “Closing Location” specified in the applicable Terms Agreement, or at such other location as may be agreed upon by the Company and the Underwriters, not later than the Closing Time.

 

(c) Payment. Payment of the purchase price for, and delivery of certificates for, the Underwritten Securities shall be made at the Closing Location, or at such other place as shall be agreed upon by the Underwriters and the Company, at the “Closing Time” specified in the applicable Terms Agreement (the “Closing Time,” the date of which being referred to as the “Closing Date”), or such other time not later than ten Business Days after such date as shall be agreed upon by the Representative and the Company. Payment shall be made to the Company by wire transfer of immediately available funds to a bank account designated in writing by the Company, against delivery to the Underwriters for the respective accounts of the Underwriters of the Underwritten Securities to be purchased by them. It is understood that each Underwriter has authorized the Representative, for its account, to accept delivery of, receipt for, and make payment of the purchase price for, the Underwritten Securities which it has severally agreed to purchase. The Representative, individually and not as representative of the Underwriters, may (but shall not be obligated to) make payment of the purchase price for the Underwritten Securities to be purchased by any Underwriter whose funds have not been received by the Closing Time, but such payment shall not relieve such Underwriter from its obligations hereunder.

 

10


 

Section 12. Indemnification and Contribution.

 

(a) The Company agrees to indemnify and hold each Underwriter and each person, if any, who controls any Underwriter within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, harmless from and against any and all losses, claims, damages, or liabilities to which such Underwriter may become subject under the Securities Act, the Exchange Act, or any other federal or state law or regulation, at common law or otherwise, insofar as such losses, claims, damages, or liabilities (and actions in respect thereof) arise out of, are based upon, or are caused by any untrue statement or allegedly untrue statement of a material fact contained in the Registration Statement, any preliminary prospectus, the Time of Sale Prospectus, the Prospectus, any Issuer Free Writing Prospectus or in any amendment or supplement thereto, or arise out of, are based upon or are caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and the Company agrees to reimburse each such indemnified party for any reasonable legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the Company will not be liable to the extent that such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of, are based upon, or are caused by any such untrue statement or omission or allegedly untrue statement or omission included in or omitted from the Registration Statement, any preliminary prospectus or the Prospectus in reliance upon and in conformity with information furnished by the Underwriters in writing expressly for use in the Registration Statement or such preliminary prospectus or the Time of Sale Prospectus or the Prospectus or any amendment or supplement thereto.

 

(b) Each Underwriter severally agrees to indemnify and hold harmless the Company, its directors, its officers who sign the Registration Statement, and each person, if any, who controls the Company within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, to the same extent as the foregoing indemnity from the Company to the Underwriters, but only with respect to such losses, claims, damages, and liabilities (and actions in respect thereof) that arise out of, are based upon, or are caused by any untrue statement or omission of a material fact or allegedly untrue statement or omission of a material fact included in or omitted from the Registration Statement, or any preliminary prospectus or the Time of Sale Prospectus or the Prospectus in reliance upon and in conformity with information furnished by the Underwriters in writing expressly for use in the Registration Statement or such preliminary prospectus or the Time of Sale Prospectus or the Prospectus or any amendment or supplement thereto.

 

(c) In case any proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought pursuant to either paragraph (a) or (b) of this Section 12, such person (the “indemnified party”) will promptly notify the person against whom such indemnity may be sought (the “indemnifying party”) in writing and the indemnifying party, upon request of the indemnified party, will retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others the indemnifying party may designate in such proceeding and will pay the fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party will have the right to retain its own counsel, but the fees and expenses of such counsel will be borne by the indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or (ii) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and, in the judgment of the indemnified party, representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood that the indemnifying party will not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all such indemnified parties and that all such reasonable fees and expenses will be reimbursed as they are incurred. Such firm will be designated in writing by the Underwriters (in the case of parties indemnified pursuant to paragraph (a) of this Section 12) or by the Company (in the case of parties indemnified pursuant to paragraph (b) of this Section 12), as the case may be. The indemnifying party will not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent, or if there shall be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. No indemnifying party will, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding. Any provision of this paragraph (c) to the contrary notwithstanding, no failure by

 

11


 

an indemnified party to notify the indemnifying party as required hereunder will relieve the indemnifying party from any liability it may have had to an indemnified party otherwise than under this Section 12 to the extent the indemnifying party is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement.

 

(d) If the indemnification provided for in paragraph (a) or (b) of this Section 12 is unavailable to an indemnified party or is insufficient in respect of any losses, claims, damages, or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying the indemnified party thereunder, will contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters, on the other, from the offering of the Underwritten Securities pursuant to the applicable Terms Agreement, or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the Underwriters, on the other, in connection with the statements or omissions that resulted in such losses, claims, damages, or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company, on the one hand, and the Underwriters, on the other, in connection with the offering of the Underwritten Securities pursuant to the applicable Terms Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of such Underwritten Securities (before deducting expenses) received by the Company and the total underwriting discount received by the Underwriters, in each case as set forth on the cover of the Prospectus, bear to the aggregate initial public offering price of such Underwritten Securities as set forth on such cover. The relative fault of the Company, on the one hand, and of the Underwriters, on the other, will be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied or to be supplied by the Company or by the Underwriters and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. The Underwriters’ respective obligations to contribute pursuant to this Section 12(d) are several in proportion to the number of Underwritten Securities set forth opposite their respective names in the applicable Terms Agreement, and not joint.

 

(e) The Company and the Underwriters agree that it would not be just or equitable if contribution pursuant to paragraph (d) above were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to therein. The amount paid or payable by an indemnified party as a result of the losses, claims, damages, and liabilities referred to in paragraph (d) above will be deemed to include, subject to the limitations set forth above, any reasonable legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Any other provisions of this Section 12 to the contrary notwithstanding, (i) the Underwriters will not be required to contribute to the Company any amount in excess of the amount by which the total price at which the Underwritten Securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of any such untrue or alleged untrue statement or omission or alleged omission (other than in reliance upon and in conformity with information furnished to the Company by the Underwriters in writing expressly for use in the Registration Statement, the preliminary prospectus or the Prospectus or any amendment or supplement thereto), and (ii) no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 

(f) The remedies provided for in this Section 12 are not exclusive and will not limit any rights or remedies that may otherwise be available to any indemnified party at law or in equity.

 

Section 13. Termination. The applicable Terms Agreement will automatically terminate upon the expiration of the offering to which the Prospectus relates. The applicable Terms Agreement may not be terminated by the Underwriters prior to delivery of and payment for such Securities except upon the failure of any of the conditions precedent described in Section 6 hereof.

 

Section 14. Survival. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters contained herein or made by or on behalf of the Company or the Underwriters pursuant hereto, any certificate delivered pursuant hereto and Section 18 shall survive the delivery of

 

12


 

and payment for the Underwritten Securities and shall remain in full force and effect, regardless of any termination of a Terms Agreement or any investigation made by or on behalf of the Company or the Underwriters.

 

Section 15. Notices. All notices, documents and other communications hereunder shall be in writing and shall be deemed received upon delivery, if delivered by hand, via facsimile transmission (with confirmation of receipt) or via email (with no indication that such email failed to reach the addressee) to a party’s address, facsimile number or email address set forth below, in the case of the Company, and in the applicable Terms Agreement, in the case of the Underwriters or the Representative (or to such other address, facsimile number or email address as a party may hereafter designate to the other parties in writing), and shall be deemed received one Business Day after having been mailed via Express Mail or deposited with Federal Express or any nationally recognized commercial courier service for “next day” delivery to such address. In the event that any Terms Agreement or any certificate or opinion to be delivered pursuant to Section 5 hereof is delivered via facsimile transmission or email, the parties will use reasonable efforts to ensure that “original” copies of such documents are distributed promptly thereafter.

 

The address, facsimile number and email address for the Company, unless otherwise specified, is as follows:

 

PepsiCo, Inc.
700 Anderson Hill Road
Purchase, New York 10577
Att’n: General Counsel
Facsimile no: 914-253-3051

 

Section 16. Successors; Non-transferability. The applicable Terms Agreement shall inure to the benefit of and be binding upon the Company and the Underwriters, their respective successors, and the officers, directors, and controlling persons referred to in Section 12 hereof. No other person will have any right or obligation hereunder. No party to the applicable Terms Agreement may assign its rights thereunder without the written consent of the other parties.

 

Section 17. Counterparts. The Terms Agreement may be signed in any number of counterparts, each of which will be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

 

Section 18. Applicable Law. These Standard Provisions and any applicable Terms Agreement will be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflicts of law.

 

Section 19. Headings. The headings of the sections of these Standard Provisions have been inserted for convenience of reference only and will not affect the construction of any of the terms or provisions hereof.

 

Section 20. No Advisory or Fiduciary Relationships. The Company acknowledges and agrees that (a) the purchase and sale of the Underwritten Securities pursuant to the Standard Provisions and the applicable Terms Agreement, including the determination of the public offering price of the Underwritten Securities and any related discounts and commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, (b) in connection with the offering contemplated hereby and the process leading to such transaction each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company, or its stockholders, creditors, employees or any other party, (c) no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) and no Underwriter has any obligation to the Company with respect to the offering contemplated hereby except the obligations expressly set forth in the Standard Provisions and the applicable Terms Agreement, (d) the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Company, and (e) the Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby and the Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.

 

13


 

Section 21. Information. The Company hereby acknowledges that, for purposes of Sections 7(b), 12(a), 12(b) and 12(e) of these Standard Provisions, the only information furnished by the Underwriters in writing expressly for use in the Registration Statement or the preliminary prospectus or the Time of Sale Prospectus or the Prospectus or any amendment or supplement thereto are those provisions identified as such in the applicable Terms Agreement.

 

14


 

Exhibit A

 

PEPSICO, INC.

 

[IDENTIFY UNDERWRITTEN SECURITIES]

 

TERMS AGREEMENT

 

[date]

 

To:                             PepsiCo, Inc.
700 Anderson Hill Road
Purchase, New York 10577

 

Ladies and Gentlemen:

 

We understand that PepsiCo, Inc., a North Carolina corporation (the “Company”), proposes to issue and sell [identify Underwritten Securities] (the “Underwritten Securities”) subject to the terms and conditions stated herein and in the PepsiCo, Inc. Underwriting Agreement Standard Provisions dated as of November 18, 2019 attached hereto as Annex A (the “Standard Provisions”). Each of the applicable provisions in the Standard Provisions (including defined terms) is incorporated herein by reference in its entirety, and shall be deemed to be a part of this Agreement to the same extent as if such provisions had been set forth in full herein. We, the underwriters named below (the “Underwriters”), offer to purchase, severally and not jointly, the amount of Underwritten Securities opposite our names set forth below at a purchase price equal to [insert purchase price(s) for Underwritten Securities].

 

 

 

Principal Amount of

 

Underwriters

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

Underwritten
Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

$

 

 

 

The Underwriters agree to reimburse the Company for $[insert reimbursement amount] of its expenses incurred in connection with the offering of the Underwritten Securities; such reimbursement to occur simultaneously with the purchase and sale of the Underwritten Securities at the Closing Time.

 

[Section 9(a)(vii) of the Standard Provisions shall apply to the Underwritten Securities.]

 

[Section 9(c), (d) and (e) of the Standard Provisions shall apply to this Agreement. The Stabilizing Manager is [Underwriter]. The Manufacturers are [Underwriter], [Underwriter] and [Underwriter].]

 


 

[Section 9(f) of the Standard Provisions shall apply to this Agreement.]

 

For purposes of Section 21 of the Standard Provisions, the identified provisions are: [(i) the fifth paragraph of text under the caption “Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus; (ii) the third sentence of the seventh paragraph of text under the caption “Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus; (iii) the eighth paragraph of text under the caption “Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus; and (iv) the tenth and eleventh paragraphs of text under the caption “Underwriting” in such preliminary prospectus, Time of Sale Prospectus and the Prospectus]. [update as necessary]

 

[Add any additional agreed terms.]

 

The undersigned are acting as the “Representative” under the Standard Provisions (the “Representatives”). The Representatives represent and warrant that they are duly authorized to execute and deliver this Terms Agreement on behalf of the several Underwriters named above.

 

The Underwritten Securities and the offering thereof shall have the following additional terms: [update as necessary]

 

Issuer:

 

PepsiCo, Inc.

Trade Date:

 

 

Time of Sale:

 

[time of sale] on the Trade Date

Settlement Date (T+[2]):

 

 

Closing Time:

 

[closing time] on the Settlement Date

Closing Location:

 

 

Time of Sale Prospectus:

 

Base prospectus dated November 18, 2019, preliminary prospectus supplement dated [pricing date] and free writing prospectus dated [pricing date]

Title of Securities:

 

 

 

 

 

 

 

 

 

 

Aggregate Principal Amount Offered:

 

 

 

 

 

 

 

 

 

 

Maturity Date:

 

 

 

 

 

 

 

 

 

 

Interest Payment Dates:

 

 

 

 

 

 

 

 

 

 

Spread to LIBOR:

 

 

 

 

 

 

 

 

 

 

Designated LIBOR Page:

 

 

 

 

 

 

 

 

 

 

Index Maturity:

 

 

 

 

 

 

 

 

 

 

Interest Reset Dates:

 

 

 

 

 

 

 

 

 

 

Initial Interest Rate:

 

 

 

 

 

 

 

 

 

 

Benchmark Treasury:

 

 

 

 

 

 

 

 

 

 

Benchmark Treasury Yield:

 

 

 

 

 

 

 

 

 

 

Spread to Treasury:

 

 

 

 

 

 

 

 

 

 

Re-offer Yield:

 

 

 

 

 

 

 

 

 

 

Coupon:

 

 

 

 

 

 

 

 

 

 

Price to Public:

 

 

 

 

 

 

 

 

 

 

Optional Redemption:

 

 

 

 

 

 

 

 

 

 

Net Proceeds to PepsiCo (Before Expenses):

 

 

 

 

 

 

 

 

 

 

 

2


 

Use of Proceeds:

 

 

 

 

 

 

 

 

 

 

Day Count Fraction:

 

 

 

 

 

 

 

 

 

 

CUSIP / ISIN:

 

 

 

 

 

 

 

 

 

 

Minimum Denomination:

 

 

 

 

 

 

 

 

 

 

Joint Book-Running Managers:

 

 

 

 

 

 

 

 

 

 

Co-Managers:

 

 

 

 

 

 

 

 

 

 

Address for Notices to the Representatives:

 

 

 

 

 

 

 

 

 

 

 

3


 

IN WITNESS WHEREOF, the parties hereto have executed this Terms Agreement as of the date first above written.

 

 

PEPSICO, INC.

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

 

 

 

By:

 

 

 

Name:

 

 

Title:

 

CONFIRMED AND ACCEPTED, as of the date first above written:

 

[NAMES OF REPRESENTATIVES]

 

as Representatives of the several Underwriters

 

By:

[REPRESENTATIVE]

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

Title:

 

 

By:

[REPRESENTATIVE]

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

Title:

 

 

By:

[REPRESENTATIVE]

 

 

 

 

 

By:

 

 

 

 

Name:

 

 

 

Title:

 

 

4


 

Schedule I

 

Time of Sale Prospectus:

 

1.                       Preliminary Prospectus dated [pricing date] (including the Base Prospectus dated November 18, 2019)

 

2.                       Any free writing prospectuses approved by the Representatives and filed by the Company under Rule 433(d) under the Securities Act

 

3.                       Final Term Sheet dated [pricing date] to be filed by the Company pursuant to Rule 433 under the Securities Act setting forth certain terms of the Underwritten Securities

 


 

Exhibit B-1

 

FORM OF OPINION OF COMPANY’S NEW YORK COUNSEL
TO BE DELIVERED PURSUANT TO SECTION 5(a)

 

[Davis Polk & Wardwell LLP Letterhead]

 

[closing date]

 

Re:                             PepsiCo, Inc.

 

[Names of Representatives]

as Representatives of the several Underwriters named in
the Underwriting Agreement referred to below

 

c/o                               [Name and address of applicable Representative]

 

Ladies and Gentlemen:

 

We have acted as special counsel for PepsiCo, Inc. (the “Company”), a North Carolina corporation, in connection with the Terms Agreement dated [pricing date] (together with the PepsiCo, Inc. Underwriting Agreement Standard Provisions (the “Standard Provisions”) dated as of November 18, 2019 incorporated therein, the “Underwriting Agreement”) among you, as representatives of the several underwriters named in the Underwriting Agreement (the “Underwriters”), and the Company, under which you and the other Underwriters have severally agreed to purchase from the Company [identify Underwritten Securities] (the “Notes”). The Notes are to be issued pursuant to the provisions of the Indenture dated as of May 21, 2007 (the “Indenture”) between the Company and The Bank of New York Mellon, as Trustee. This opinion is being delivered to you at the request of the Company pursuant to Section 5(a) of the Standard Provisions.

 

We have examined originals or copies of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary or advisable for the purpose of rendering this opinion.

 

We have participated in the preparation of the Company’s registration statement on Form S-3 (File No. 333-[file number]) (other than the documents incorporated by reference therein (the “Incorporated Documents”)) filed with the Securities and Exchange Commission (the “Commission”) pursuant to the provisions of the Securities Act of 1933, as amended (the “Act”), relating to the registration of securities (the “Shelf Securities”) to be issued from time to time by the Company, the preliminary prospectus supplement dated [pricing date] relating to the Notes, the final term sheet dated [pricing date] describing certain terms of the Notes filed by the Company with the Commission pursuant to Rule 433 under the Act (the “Issuer Free Writing Prospectus”) and the prospectus supplement dated [pricing date] relating to the Notes (the “Prospectus Supplement”), and have reviewed the Incorporated Documents. The registration statement became effective under the Act upon the filing thereof with the Commission on November 18, 2019 pursuant to Rule 462(e) under the Act. The registration statement at the date of the Underwriting Agreement, including the Incorporated Documents and the information deemed to be part of the registration statement at the time of effectiveness pursuant to Rule 430B under the Act, is hereinafter referred to as the “Registration Statement,” and the related prospectus (including the Incorporated Documents) dated November 18, 2019 relating to the Shelf Securities is hereinafter referred to as the “Basic Prospectus.” The Basic Prospectus, as supplemented by the Prospectus Supplement, in the form first used to confirm sales of the Notes (or in the form first made available by the Company to the Underwriters to meet requests of purchasers of the Notes under Rule 173 under the Act), is hereinafter referred to as the “Prospectus.”

 

In rendering the opinions expressed herein, we have, without independent inquiry or investigation, assumed that (i) all documents submitted to us as originals are authentic and complete, (ii) all documents submitted to us as copies conform to authentic, complete originals, (iii) all documents filed with or submitted to the Commission through its Electronic Data Gathering, Analysis and Retrieval (“EDGAR”) system (except for required EDGAR formatting changes) conform to the versions of such documents reviewed by us prior to such formatting, (iv) all signatures on all documents that we reviewed are genuine, (v) all natural persons

 


 

executing documents had and have the legal capacity to do so, (vi) all statements in certificates of public officials and officers of the Company that we reviewed were and are accurate and (vii) all representations made by the Company as to matters of fact in the documents that we reviewed were and are accurate.

 

Based upon the foregoing, and subject to the additional assumptions and qualifications set forth below, we are of the opinion that:

 

1.                                      The Indenture was duly qualified under the Trust Indenture Act of 1939, as amended, and assuming due authorization, execution and delivery thereof by the Company, the Indenture is a valid and binding agreement of the Company, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability, provided that we express no opinion as to (x) the enforceability of any waiver of rights under any usury or stay law or (y) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above.

 

2.                                      Assuming the due authorization of the Notes by the Company, the Notes, when executed and authenticated in accordance with the provisions of the Indenture and delivered to and paid for by the Underwriters pursuant to the Underwriting Agreement, will be valid and binding obligations of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability, and will be entitled to the benefits of the Indenture pursuant to which such Notes are to be issued, provided that we express no opinion as to (x) the enforceability of any waiver of rights under any usury or stay law or (y) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above.

 

3.                                      No consent, approval, authorization, or order of, or qualification with, any governmental body or agency under the laws of the State of New York or any federal law of the United States of America that in our experience is normally applicable to general business corporations in relation to transactions of the type contemplated by the Indenture, the Notes and the Underwriting Agreement (collectively, the “Documents”) is required for the execution, delivery and performance by the Company of its obligations under the Documents, except such as may be required under federal or state securities or Blue Sky laws as to which we express no opinion in this paragraph (3).

 

4.                                      Any required filing of the Prospectus pursuant to Rule 424(b) under the Act has been made in the manner and within the time period required by Rule 424(b) under the Act; any required filing of the Issuer Free Writing Prospectus pursuant to Rule 433 under the Act has been made in the manner and within the time period required by Rule 433(d) under the Act; and, to our knowledge, no stop order suspending the effectiveness of the Registration Statement has been issued under the Act and no proceedings for that purpose have been instituted or are pending or threatened by the Commission.

 

5.                                      We have considered the statements included in the Prospectus under the captions “Description of Notes” and “Description of Debt Securities” insofar as they summarize provisions of the Indenture and the Notes. In our opinion, such statements fairly summarize these provisions in all material respects.

 

6.                                      The statements included in the Prospectus under the caption “United States Federal Income Tax Considerations,” insofar as they purport to describe provisions of U.S. federal income tax laws or legal conclusions with respect thereto, fairly and accurately summarize the matters referred to therein in all material respects.

 

In rendering the opinions in paragraphs (1) and (2) above, we have assumed that each party to the Documents has been duly incorporated and is validly existing and in good standing under the laws of the

 

2


 

jurisdiction of its organization. In addition, we have assumed that the execution, delivery and performance by each party thereto of each Document to which it is a party, (i) are within its corporate powers, (ii) do not contravene, or constitute a default under, the certificate of incorporation or bylaws or other constitutive documents of such party, (iii) other than as expressly covered in paragraph (3) above in respect of the Company, require no action by or in respect of, or filing with, any governmental body, agency or official and (iv) do not contravene, or constitute a default under, any provision of applicable law or regulation or any judgment, injunction, order or decree or any agreement or other instrument binding upon such party, and that each Document is a valid, binding and enforceable agreement of each party thereto, other than the Company.

 

We are members of the Bar of the State of New York, and the foregoing opinion is limited to the laws of the State of New York and the federal laws of the United States of America. Insofar as the foregoing opinion involves matters governed by the laws of the State of North Carolina, we have relied without independent inquiry or investigation, on the opinion of Womble Bond Dickinson (US) LLP delivered to you today pursuant to the Underwriting Agreement.

 

This opinion is rendered solely to you and the other several Underwriters in connection with the Underwriting Agreement. This opinion may not be relied upon by you for any other purpose or relied upon by any other person (including any person acquiring Notes from the several Underwriters) or furnished to any other person without our prior written consent.

 

Very truly yours,

 

3


 

Exhibit B-2

 

FORM OF DISCLOSURE LETTER OF COMPANY’S NEW YORK
COUNSEL TO BE DELIVERED PURSUANT TO SECTION 5(a)

 

[Davis Polk & Wardwell LLP Letterhead]

 

[closing date]

 

Re:                             PepsiCo, Inc.

 

[Names of Representatives]

as Representatives of the several Underwriters named in
the Underwriting Agreement referred to below

 

c/o                               [Name and address of applicable Representative]

 

Ladies and Gentlemen:

 

We have acted as special counsel for PepsiCo, Inc. (the “Company”), a North Carolina corporation, in connection with the Terms Agreement dated [pricing date] (together with the PepsiCo, Inc. Underwriting Agreement Standard Provisions (the “Standard Provisions”) dated as of November 18, 2019 incorporated therein, the “Underwriting Agreement”) among you, as representatives of the several underwriters named in the Underwriting Agreement (the “Underwriters”), and the Company, under which you and the other Underwriters have severally agreed to purchase from the Company [identify Underwritten Securities] (the “Notes”). The Notes are to be issued pursuant to the provisions of the Indenture dated as of May 21, 2007 (the “Indenture”) between the Company and The Bank of New York Mellon, as Trustee. This opinion is being delivered to you at the request of the Company pursuant to Section 5(a) of the Standard Provisions.

 

We have participated in the preparation of the Company’s registration statement on Form S-3 (File No. 333-[file number]) (other than the documents incorporated by reference therein (the “Incorporated Documents”)) filed with the Securities and Exchange Commission (the “Commission”) pursuant to the provisions of the Securities Act of 1933, as amended (the “Act”), relating to the registration of securities (the “Shelf Securities”) to be issued from time to time by the Company, the preliminary prospectus supplement dated [pricing date] (the “Preliminary Prospectus Supplement”) relating to the Notes, the final term sheet dated [pricing date] describing certain terms of the Notes filed by the Company with the Commission pursuant to Rule 433 under the Act (the “Issuer Free Writing Prospectus”) and the prospectus supplement dated [pricing date] relating to the Notes (the “Prospectus Supplement”), and have reviewed the Incorporated Documents. The registration statement became effective under the Act upon the filing of the registration statement with the Commission on November 18, 2019 pursuant to Rule 462(e) under the Act. The registration statement at the date of the Underwriting Agreement, including the Incorporated Documents and the information deemed to be part of the registration statement at the time of effectiveness pursuant to Rule 430B under the Act, is hereinafter referred to as the “Registration Statement,” and the related prospectus (including the Incorporated Documents) dated November 18, 2019 relating to the Shelf Securities is hereinafter referred to as the “Basic Prospectus.” The Basic Prospectus, as supplemented by the Preliminary Prospectus Supplement, together with the Issuer Free Writing Prospectus, are hereinafter referred to as the “Disclosure Package.” The Basic Prospectus, as supplemented by the Prospectus Supplement, in the form first used to confirm sales of the Notes (or in the form first made available by the Company to the Underwriters to meet requests of purchasers of the Notes under Rule 173 under the Act), is hereinafter referred to as the “Prospectus.”

 

We have, without independent inquiry or investigation, assumed that all documents filed with or submitted to the Commission through its Electronic Data Gathering, Analysis and Retrieval (“EDGAR”) system (except for required EDGAR formatting changes) conform to the versions of such documents reviewed by us prior to such formatting.

 

The primary purpose of our professional engagement was not to establish or confirm factual matters or financial, accounting or quantitative information. Furthermore, many determinations involved in the

 


 

preparation of the Registration Statement, the Disclosure Package and the Prospectus are of a wholly or partially non-legal character or relate to legal matters outside the scope of our opinion separately delivered to you today in respect of certain matters under the laws of the State of New York and the federal laws of the United States of America. As a result, we are not passing upon, and do not assume any responsibility for, the accuracy, completeness or fairness of the statements contained in the Registration Statement, the Disclosure Package or the Prospectus, and we have not ourselves checked the accuracy, completeness or fairness of, or otherwise verified, the information furnished in such documents (except to the extent expressly set forth in our opinion letter separately delivered to you today as to statements included in the Prospectus under the captions “Description of Notes,” “United States Federal Income Tax Considerations” and “Description of Debt Securities”). However, in the course of our acting as counsel to the Company in connection with the preparation of the Registration Statement, the Disclosure Package and the Prospectus, we have generally reviewed and discussed with your representatives and your counsel and with certain officers and employees of, and independent public accountants for, the Company the information furnished, whether or not subject to our check and verification. We have also reviewed and relied upon certain corporate records and documents, letters from counsel and accountants and oral and written statements of officers and other representatives of the Company and others as to the existence and consequence of certain factual and other matters.

 

On the basis of the information gained in the course of the performance of the services rendered above, but without independent check or verification except as stated above:

 

(i)                                     the Registration Statement and the Prospectus appear on their face to be appropriately responsive in all material respects to the requirements of the Act and the applicable rules and regulations of the Commission thereunder; and

 

(ii)                                  nothing has come to our attention that causes us to believe that, insofar as relevant to the offering of the Notes:

 

(a)                                 on the date of the Underwriting Agreement, the Registration Statement contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading,

 

(b)                                 at [time of sale] (New York City time) on [pricing date], the Disclosure Package contained any untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or

 

(c)                                  the Prospectus as of the date of the Underwriting Agreement or as of the date hereof contained or contains any untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

In providing this letter to you and the other several Underwriters, we have not been called to pass upon, and we express no view regarding, the financial statements or financial schedules or other financial or accounting data included in the Registration Statement, the Disclosure Package or the Prospectus, or the Statement of Eligibility of the Trustee on Form T-1. In addition, we express no view as to the conveyance of the Disclosure Package or the information contained therein to investors.

 

This letter is delivered solely to you and the other several Underwriters in connection with the Underwriting Agreement. This letter may not be relied upon by you for any other purpose or relied upon by any other person (including any person acquiring Notes from the several Underwriters) or furnished to any other person without our prior written consent.

 

Very truly yours,

 

2


 

Exhibit B-3

 

FORM OF OPINION OF COMPANY’S INTERNAL COUNSEL TO BE
DELIVERED PURSUANT TO SECTION 5(a)

 

[PepsiCo, Inc. Letterhead]

 

[closing date]

 

Re:                             PepsiCo, Inc.

 

[Names of Representatives]

as Representatives of the several Underwriters named in
the Underwriting Agreement referred to below

 

c/o                               [Name and address of applicable Representative]

 

I am Senior Vice President, Corporate Law and Deputy Corporate Secretary of PepsiCo, Inc., a North Carolina corporation (the “Company”), and have acted in such capacity in connection with the Terms Agreement dated [pricing date] (together with the PepsiCo, Inc. Underwriting Agreement Standard Provisions (the “Standard Provisions”) dated as of November 18, 2019 incorporated therein, the “Underwriting Agreement”) among you, as representatives of the several underwriters (the “Underwriters”) named in the Underwriting Agreement, and the Company, under which you and the other Underwriters have severally agreed to purchase from the Company [identify Underwritten Securities] (the “Notes”). The Notes are to be issued pursuant to the provisions of an Indenture dated as of May 21, 2007 (the “Indenture”) between the Company and The Bank of New York Mellon, as Trustee (the “Trustee”). This opinion is being delivered to you at the request of the Company pursuant to Section 5(a) of the Standard Provisions. Capitalized terms used but not defined herein have the meanings given to them in the Underwriting Agreement.

 

I have examined originals or copies, certified or otherwise identified to my satisfaction, of such documents, corporate records, certificates of public officials and other instruments as I have deemed necessary for the purpose of rendering this opinion. I have assumed the capacity of all natural persons and the genuineness of all signatures.

 

Based upon the foregoing and subject to the limitations set forth below, I am of the opinion that:

 

1.                                      The execution, delivery and performance by the Company of its obligations under the Underwriting Agreement, the Indenture and the Notes will not contravene any provision of the Amended and Restated Articles of Incorporation or By-Laws of the Company, or of any agreement or other instrument binding upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries taken as a whole, or, to my knowledge, of any judgment, order, or decree of any governmental body, agency, or court having jurisdiction over the Company or any of its subsidiaries, in each of the foregoing cases except as would not reasonably be expected to have a material adverse effect on the business, financial condition or results of operations of the Company and its subsidiaries, taken as a whole.

 

2.                                      To my knowledge, there is no legal or governmental proceeding pending or threatened to which the Company or any of its significant subsidiaries is a party, or by which any of the properties of the Company or its significant subsidiaries is bound, which would reasonably be expected to have a material adverse effect on the business, financial condition or results of operations of the Company and its subsidiaries, taken as a whole; and to my knowledge, there is no agreement or other document that is required to be described in the Registration Statement, the Prospectus or the Time of Sale Prospectus, or that is required to be filed as an exhibit to the Registration Statement, that is not so described or filed.

 

In rendering the foregoing opinion, I have relied, as to matters of fact, to the extent I have deemed proper, on certificates of responsible officers of the Company and public officials. I am a member of the Bar of the

 


 

State of New York, and the foregoing opinion is limited to the laws of the State of New York and the federal laws of the United States of America. Insofar as this opinion involves matters governed by the laws of the State of North Carolina, I have relied, with your permission and without independent investigation, on the opinion delivered to you today by Womble Bond Dickinson (US) LLP, North Carolina counsel for the Company.

 

This opinion is rendered solely to you and the other several Underwriters in connection with the Underwriting Agreement. This opinion may not be relied upon by you for any other purpose or relied upon by any other person (including any person acquiring the Notes from you) or furnished to any other person without my prior written consent.

 

Very truly yours,

 

2


 

Exhibit B-4

 

FORM OF OPINION OF COMPANY’S NORTH CAROLINA COUNSEL
TO BE DELIVERED PURSUANT TO SECTION 5(a)

 

[Womble Bond Dickinson (US) LLP Letterhead]

 

[closing date]

 

Re:                             PepsiCo, Inc.

 

[Names of Representatives]

as Representatives of the several Underwriters named in
the Underwriting Agreement referred to below

 

c/o                               [Name and address of applicable Representative]

 

Ladies and Gentlemen:

 

We have acted as special North Carolina counsel to PepsiCo, Inc., a North Carolina corporation (the “Company”), in connection with the Terms Agreement dated [pricing date] (incorporating by reference the PepsiCo, Inc. Underwriting Agreement Standard Provisions (the “Standard Provisions”) dated as of November 18, 2019) (the “Terms Agreement” and, together with the Standard Provisions, the “Underwriting Agreement”) between the Company and you, as representatives of the several underwriters named in the Underwriting Agreement (the “Underwriters”), under which you and the other Underwriters have severally agreed to purchase from the Company [identify Underwritten Securities] (the “Notes”). The Notes are to be issued pursuant to the provisions of an indenture dated as of May 21, 2007 between the Company and The Bank of New York Mellon, as trustee (the “Indenture”). This opinion is delivered to you pursuant to Section 5(a) of the Standard Provisions. Capitalized terms used and not otherwise defined in this opinion have the meanings given to them in the Underwriting Agreement.

 

As the Company’s special North Carolina counsel, we have reviewed the Company’s articles of incorporation and by-laws, each as amended to date, and the Underwriting Agreement, and have examined the originals, or copies certified or otherwise identified to our satisfaction, of corporate records, certificates of public officials and of representatives of the Company, statutes and other instruments and documents, as a basis for the opinions hereinafter expressed. In rendering this opinion, we have relied upon certificates of public officials and representatives of the Company with respect to the accuracy of the factual matters contained in such certificates.

 

In connection with such review, we have assumed with your permission: (a) that the Underwriting Agreement, the Indenture and all other documents that are the subject of this opinion or on which this opinion is based (the “Transaction Documents”) have been properly authorized, executed and delivered by each of the respective parties thereto other than the Company; (b) the genuineness of all signatures and the legal capacity of all signatories; (c) the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as certified or photostatic copies; (d) the proper issuance and accuracy of certificates of public officials and representatives of the Company; (e) the due authentication of the Notes in accordance with the Indenture and payment by the Underwriters of the purchase price for the Notes in accordance with the Underwriting Agreement; and (f) the truth and accuracy of the representations, warranties and covenants of the Underwriters set forth in the Underwriting Agreement.

 

This opinion is limited to the laws of the State of North Carolina, excluding local laws of the State of North Carolina (i.e., the statutes and ordinances, the administrative decisions and the rules and regulations of counties, towns, municipalities and special political subdivisions of, or authorities or quasi-governmental bodies constituted under the laws of, the State of North Carolina and judicial decisions to the extent they deal with any of the foregoing) and the securities or Blue Sky laws of the State of North Carolina, and we are expressing no opinion as to the effect of the laws of any other jurisdiction.

 


 

The opinion in paragraph 1 relating to the existence of the Company in the State of North Carolina is given solely in reliance on a certificate of existence issued by the Secretary of State of the State of North Carolina dated [date].

 

Based on and subject to the foregoing and the qualifications and limitations set forth below, and having regard for such legal considerations as we deem relevant, it is our opinion that:

 

1.                                      The Company is a corporation in existence under the laws of the State of North Carolina, with corporate power to conduct its business as described in the Time of Sale Prospectus and the Prospectus.

 

2.                                      The Company has authorized by all necessary corporate action the execution and delivery of the Underwriting Agreement, the Indenture and the Notes.

 

3.                                      The Underwriting Agreement, the Indenture and the Notes have been duly executed and delivered by the Company.

 

4.                                      The execution and delivery of and performance by the Company of its obligations under the Underwriting Agreement, the Indenture and the Notes do not violate any provision of the articles of incorporation or by-laws of the Company.

 

5.                                      No consent, approval, authorization, or order of or qualification with any North Carolina governmental body or agency is required to be obtained or made by the Company for the execution, delivery and performance by the Company of the Underwriting Agreement or the issuance of the Notes, except as may be required by the Blue Sky or other securities laws if the Notes are offered or sold in North Carolina and except for consents, approvals, authorizations, actions, filings and registrations which, if not obtained or made, are not reasonably likely to have a material adverse effect on the business, financial condition or results of operations of the Company and its subsidiaries, taken as a whole.

 

Nothing contained in this opinion letter shall be construed as an opinion as to the enforceability of the Transaction Documents or as an opinion as to whether the execution and delivery of the Indenture and the Notes, or the authorization thereof, comply with applicable provisions of such instruments and of the Trust Indenture Act of 1939, as amended. This opinion letter is delivered solely for your benefit in connection with the Underwriting Agreement and the transactions provided for therein and may not be quoted in whole or in part, referred to, filed with any governmental agency or otherwise used or relied upon by any other person or for any other purpose without our prior written consent.

 

This opinion is rendered as of the date hereof, and we undertake no obligation to advise you of any changes in applicable law or any other matters that may come to our attention after the date hereof.

 

Very truly yours,

 

2


 

Exhibit C

 

FORM OF ASSISTANT SECRETARY’S CERTIFICATE

 

I, [name], a duly qualified, elected and acting Assistant Secretary of PepsiCo, Inc., a company organized under the laws of the State of North Carolina (the “Company”), hereby certify in the name of and on behalf of the Company, pursuant to Sections 5(c) and 6(d) of the PepsiCo, Inc. Underwriting Agreement Standard Provisions dated as of November 18, 2019, incorporated into the Terms Agreement, dated [pricing date] (the “Terms Agreement”), among the Company and [identify Representatives], as the representatives of the several Underwriters listed in the Terms Agreement, as follows (capitalized terms used herein without definition have the meanings ascribed to them in the Terms Agreement):

 

1.             Attached hereto as Exhibit A is a true and complete copy of the Amended and Restated Articles of Incorporation of the Company, in effect and certified by the Secretary of State of the State of North Carolina as of [date]. No further amendments or supplements to the Amended and Restated Articles of Incorporation have been proposed to or approved by the Board of Directors or shareholders of the Company.

 

2.             Attached hereto as Exhibit B is a true, correct, and complete copy of the By-Laws of the Company. Such By-Laws have been in effect at all times since January 11, 2016 [update as necessary].

 

3.             Attached hereto as Exhibits C-1, C-2, C-3, C-4, C-5 and C-6 are true, correct and complete copies of certain resolutions duly adopted by the Board of Directors of the Company on March 17, 2006, February 7, 2013 (as amended by resolutions duly adopted by the Board of Directors of the Company on February 2, 2017, July 11, 2019 and November 14, 2019), and November 14, 2019 [update as necessary]. Except as expressly set forth in such resolutions, such resolutions have not been amended or modified, are in full force and effect in the form adopted as of the date of this Certificate and are the only resolutions adopted by the Board of Directors of the Company or a duly authorized committee thereof that are in full force and effect relating to (i) the authorization of the Company’s Registration Statement on Form S-3 (Registration No. 333-[file number]) (the “Registration Statement”), filed with the Securities and Exchange Commission (the “Commission”) for the registration of the Underwritten Securities; (ii) the execution and delivery of the Terms Agreement; (iii) the execution and delivery of the Indenture, dated as of May 21, 2007 (the “Indenture”), by and between the Company and The Bank of New York Mellon, as trustee; (iv) the issuance and sale of the Underwritten Securities; and (v) all other actions relating to the foregoing.

 

4.             Attached hereto as Exhibit D is a true, complete and correct copy of the CEO Delegation of Authority Regarding Indebtedness, executed on February 2, 2017 by Indra K. Nooyi, the then CEO of the Company [update as necessary].

 

5.             Each person who, as a director or officer of the Company or attorney-in-fact of such director or officer, signed (i) the Registration Statement, (ii) the Terms Agreement, (iii) the Indenture, (iv) the certificates representing the Underwritten Securities, and (v) any document delivered prior hereto or on the date of this Certificate in connection with the execution and filing of the Registration Statement, or the execution and delivery of the Terms Agreement, or the transactions contemplated thereby, or the execution and delivery of the certificates representing the Underwritten Securities, was, at the time or the respective times of such execution and delivery of such documents, and, in the case of the filing of the Registration Statement with the Commission, at the time of such filing, duly elected or appointed, qualified and acting as such director or officer or duly appointed and acting as such attorney-in-fact and the signatures of such persons appearing on such documents are their genuine signatures or, in case of the certificates evidencing the Underwritten Securities, the true facsimile thereof.

 

6.             The minute book records of the Company relating to proceedings of the Board of Directors of the Company made available to Jones Day, counsel for the Underwriters, and Davis Polk & Wardwell LLP, counsel to the Company, are true and correct and constitute all such records in the possession and control of the Company through and including [closing date].

 


 

7.             Attached hereto as Exhibits E-1, E-2, E-3, E-4 and E-5 [update as necessary] are true and correct specimens of the certificates representing the Underwritten Securities.

 

8.             The persons named below are duly qualified, elected, and acting officers of the Company, have been duly elected or appointed to the offices set forth opposite their respective names, have held such offices at all times relevant to the preparation of the Registration Statement, the Terms Agreement, the Indenture and the issuance and sale of the Underwritten Securities and hold such offices as of the date hereof. The signatures set forth below opposite the names of such persons are the genuine signatures of such persons.

 

Name

 

Office

 

Signature

[name]

 

[title]

 

 

[name]

 

[title]

 

 

 

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the Company as of the      day of            , 20  .

 

[seal]

 

 

By:

 

 

 

Name:

[name]

 

 

Title:

Assistant Secretary

 

2


 

I, [name], [title] of the Company, hereby certify that [name] is a duly qualified, elected and acting Assistant Secretary of the Company, has been duly elected or appointed to such office, has held such office at all times relevant to the preparation of the Registration Statement, holds such office as of the date hereof, and that the signature set forth above is her genuine signature.

 

IN WITNESS WHEREOF, I have hereunto set my hand as of the      day of            , 20  .

 

 

By:

 

 

 

Name:

[name]

 

 

Title:

[title]

 

3


 

Exhibit D

 

FORM OF OFFICER’S CERTIFICATE

 

I, [name], [title] of PepsiCo, Inc., a corporation organized under the laws of the State of North Carolina (the “Company”), hereby certify in the name of and on behalf of the Company, pursuant to Sections 5(d) and 6(d) of the PepsiCo, Inc. Underwriting Agreement Standard Provisions dated as of November 18, 2019, incorporated into the Terms Agreement, dated [pricing date] (the “Terms Agreement”), among the Company and [identify Representatives], as the representatives of the several Underwriters listed in the Terms Agreement, as follows (capitalized terms used herein without definition have the meanings ascribed to them in the Terms Agreement):

 

1.              I have examined the Company’s Registration Statement on Form S-3, File No. 333-[file number] (the “Registration Statement”), as filed by the Company with the Securities and Exchange Commission (the “Commission”) on November 18, 2019, the Prospectus and the Time of Sale Prospectus, in each case including all of the documents filed as exhibits thereto;

 

2.              To my knowledge, no proceedings for the merger, consolidation, liquidation, or dissolution of the Company or the sale of all or substantially all of its assets are pending or contemplated; and

 

3.              To my knowledge, (A) the Registration Statement as supplemented by the Time of Sale Prospectus (i) contains no untrue statement of a material fact regarding the Company or any of its consolidated subsidiaries, and (ii) does not omit to state any material fact necessary to make any such statement, in the light of the circumstances under which it was made, not misleading; and (B) no stop order suspending the effectiveness of the Registration Statement has been issued under the Securities Act.

 

IN WITNESS WHEREOF, the undersigned has hereunto signed his name this      day of            , 20  .

 

 

By:

 

 

 

Name:

[name]

 

 

Title:

[title]

 



EX-5.1 4 a2240066zex-5_1.htm EX-5.1

Exhibits 5.1 and 23.2

 

OPINION OF DAVIS POLK & WARDWELL LLP

 

November 18, 2019

 

PepsiCo, Inc.
700 Anderson Hill Road
Purchase, New York 10577

 

Ladies and Gentlemen:

 

PepsiCo, Inc. (the “Company”), a North Carolina corporation, is filing with the Securities and Exchange Commission a registration statement on Form S-3 (the “Registration Statement”) for the purpose of registering under the Securities Act of 1933, as amended (the “Securities Act”), (a) shares of common stock, par value one and two-thirds cents (1-2/3 cents) per share, of the Company (the “Common Stock”); (b) the Company’s senior debt securities and subordinated debt securities (collectively, the “Debt Securities”), which may be issued pursuant to an Indenture (the “Indenture”) dated as of May 21, 2007 between the Company and The Bank of New York Mellon, as trustee (the “Trustee”); (c) warrants of the Company (the “Warrants”), which may be issued pursuant to a warrant agreement (the “Warrant Agreement”) between the Company and the warrant agent to be named therein; and (d) units (the “Units”) to be issued under one or more unit agreements to be entered into among the Company, a bank or trust company, as unit agent (the “Unit Agent”), and the holders from time to time of the Units (each such unit agreement, a “Unit Agreement”).

 

We, as your counsel, have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary or advisable for the purpose of rendering this opinion.

 

Based upon the foregoing, we advise you that, in our opinion:

 

1.              When the Indenture and any supplemental indenture to be entered into in connection with the issuance of any Debt Securities have been duly authorized, executed and delivered by the Trustee and the Company; the specific terms of a particular series of Debt Securities have been duly authorized and established in accordance with the Indenture; and such Debt Securities have been duly authorized, executed, authenticated, issued and delivered in accordance with the Indenture and the applicable underwriting or other agreement against payment therefor, such Debt Securities will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability.

 

2.              When the Warrant Agreement to be entered into in connection with the issuance of any Warrants has been duly authorized, executed and delivered by the Warrant Agent and the Company; the specific terms of the Warrants have been duly authorized and established in accordance with the Warrant Agreement; and such Warrants have been duly authorized, executed, issued and delivered in accordance with the Warrant Agreement and the applicable underwriting or other agreement against payment therefor, such Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability.

 

3.              When the Unit Agreement to be entered into in connection with the issuance of any Units has been duly authorized, executed and delivered by the Unit Agent and the Company; the specific terms of the Units have been duly authorized and established in accordance with the Unit Agreement; and such Units have been duly authorized, executed, issued and delivered in accordance with the Unit

 


 

Agreement and the applicable underwriting or other agreement against payment therefor, such Units will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability.

 

In connection with the opinions expressed above, we have assumed that, at or prior to the time of the delivery of any such security, (i) the Board of Directors shall have duly established the terms of such security and duly authorized the issuance and sale of such security and such authorization shall not have been modified or rescinded; (ii) the Company is, and shall remain, validly existing as a corporation in good standing under the laws of the State of North Carolina; (iii) the Registration Statement shall have been declared effective and such effectiveness shall not have been terminated or rescinded; (iv) the Indenture and the Debt Securities are each valid, binding and enforceable agreements of each party thereto (other than as expressly covered above in respect of the Company); and (v) there shall not have occurred any change in law affecting the validity or enforceability of such security. We have also assumed (i) that none of the terms of any security to be established subsequent to the date hereof, nor the issuance and delivery of such security, nor the compliance by the Company with the terms of such security will violate any applicable law or public policy or will result in a violation of any provision of any instrument or agreement then binding upon the Company, or any restriction imposed by any court or governmental body having jurisdiction over the Company; (ii) that any Warrant Agreement and any Unit Agreement will be governed by the laws of the State of New York; and (iii) the accuracy of the opinion of Womble Bond Dickinson (US) LLP rendered to you with respect to the validity, full payment and non-assessability of the Common Stock and filed as an exhibit to the Registration Statement.

 

We are members of the Bar of the State of New York and the foregoing opinion is limited to the laws of the State of New York.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement referred to above and further consent to the reference to our name under the caption “Validity of Securities” in the prospectus, which is a part of the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.

 

This opinion is rendered solely to you in connection with the above matter. This opinion may not be relied upon by you for any other purpose or relied upon by or furnished to any other person without our prior written consent.

 

Very truly yours,

 

/s/ DAVIS POLK & WARDWELL LLP

 

2



EX-5.2 5 a2240066zex-5_2.htm EX-5.2

Exhibits 5.2 and 23.3

 

OPINION OF WOMBLE BOND DICKINSON (US) LLP

 

November 18, 2019

 

PepsiCo, Inc.
700 Anderson Hill Road
Purchase, New York 10577

 

Re:     Registration Statement on Form S-3

 

Ladies and Gentlemen:

 

We have acted as special North Carolina counsel to PepsiCo, Inc., a North Carolina corporation (the “Company”), in connection with the preparation of the Company’s above-referenced registration statement on Form S-3 (the “Registration Statement”) under the Securities Act of 1933, as amended (the “1933 Act”), filed by the Company with the Securities and Exchange Commission (the “Commission”) on November 18, 2019. The Registration Statement relates to the proposed offer and sale by the Company of the following securities (collectively, the “Securities”): (a) shares of common stock, par value 1-2/3 cents per share (the “Common Stock”); (b) debt securities; (c) warrants and (d) units. The Registration Statement provides that specific terms of the Securities will be provided in supplements to the prospectus contained in the Registration Statement.

 

This opinion is delivered to you pursuant to Item 16 of Form S-3 and Item 601(b)(5) of Regulation S-K of the Commission. This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the 1933 Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, the prospectus or any prospectus supplement other than as expressly stated herein with respect to the issuance of the Securities.

 

As the Company’s special North Carolina counsel, we have examined originals or copies, certified or otherwise identified to our satisfaction, of the Company’s articles of incorporation and by-laws, each as amended to date, and minutes and records of the corporate proceedings of the Company relating to the filing of the Registration Statement and the issuance of the Common Stock, as provided to us by the Company, certificates of public officials and of representatives of the Company, and statutes and other instruments and documents, as a basis for the opinions hereinafter expressed. In rendering this opinion, we have relied upon certificates of public officials and representatives of the Company with respect to the accuracy of the factual matters contained in such certificates.

 

In connection with such examination, we have assumed (a) the genuineness of all signatures and the legal capacity of all signatories; (b) the authenticity of all documents submitted to us as originals and the conformity to original documents of all documents submitted to us as certified or photostatic copies; (c) that each agreement relating to the issuance of the Common Stock constitutes the enforceable obligation of the parties thereto other than the Company; (d) the proper issuance and accuracy of certificates of public officials and representatives of the Company; (e) that at the time of any offering or sale of any shares of Common Stock, the Company will have such number of shares of Common Stock, as set forth in such offering or sale, duly authorized and available for issuance; (f) that the issuance of such Common Stock, whether represented by certificates or issued in uncertificated form, will be registered on the stock transfer books of the Company in compliance with applicable law and the Company’s by-laws, as amended, and any certificates representing the Common Stock will be duly executed in accordance with applicable law and the Company’s by-laws, as amended; and (g) that there shall not have occurred any change in law affecting the validity of the Common Stock.

 

Based on and subject to the foregoing, and subject to completion of all corporate action required to be taken by the Company to authorize each proposed issuance of Securities (including the due reservation of

 


 

any shares of Common Stock to be issued upon conversion, exercise or exchange or otherwise pursuant to the terms of any other Securities), and having regard for such legal considerations as we deem relevant, it is our opinion that:

 

1.             With respect to Common Stock, when the shares of Common Stock have been issued and delivered in accordance with the applicable definitive purchase, underwriting or similar agreement against the receipt of requisite consideration therefor provided for therein, such shares of Common Stock will be validly issued, fully paid and nonassessable.

 

2.             With respect to Common Stock to be issued upon conversion, exercise, exchange or otherwise pursuant to the terms of any other Securities, when such Common Stock has been issued and delivered in accordance with the terms of the applicable Securities and the applicable definitive purchase, underwriting or similar agreement against the receipt of requisite consideration therefor provided for therein, such shares of Common Stock will be validly issued, fully paid and nonassessable.

 

This opinion is limited to the laws of the State of North Carolina, and we are expressing no opinion as to the effect of the laws of any other jurisdiction.

 

This opinion is rendered as of the date hereof, and we undertake no obligation to advise you of any changes in applicable law or any other matters that may come to our attention after the date hereof.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to any reference to the name of our firm in the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the 1933 Act or the rules and regulations of the Commission thereunder.

 

 

Very truly yours,

 

 

 

/s/ WOMBLE BOND DICKINSON (US) LLP

 

2



EX-15.1 6 a2240066zex-15_1.htm EX-15.1

Exhibit 15.1

 

Accountant’s Acknowledgment

 

Board of Directors and Shareholders
PepsiCo, Inc.:

 

Re:          Registration Statement on Form S-3 filed with the Securities and Exchange Commission

 

With respect to the subject registration statement, we acknowledge our awareness of the incorporation by reference therein of our reports dated April 17, 2019, July 9, 2019 and October 3, 2019, related to our reviews of PepsiCo Inc. and Subsidiaries’ interim financial information.

 

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such reports are not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

 

 

/s/ KPMG LLP

 

 

New York, New York

 

November 18, 2019

 

 



EX-23.1 7 a2240066zex-23_1.htm EX-23.1

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

Board of Directors and Shareholders
PepsiCo, Inc.:

 

We consent to the incorporation by reference in the Registration Statement on Form S-3 (the “Registration Statement”) of PepsiCo, Inc. and subsidiaries (“PepsiCo, Inc.”) of our report dated February 15, 2019, with respect to the consolidated Balance Sheets of PepsiCo, Inc. as of December 29, 2018 and December 30, 2017, and the related Consolidated Statements of Income, Comprehensive Income, Cash Flows, and Equity for each of the fiscal years in the three-year period ended December 29, 2018, and the related notes (collectively, the “consolidated financial statements”), and the effectiveness of internal control over financial reporting as of December 29, 2018, which report appears in the December 29, 2018 annual report on Form 10-K of PepsiCo, Inc. and to the reference to our firm under the heading “Experts” in the Registration Statement.

 

Our report dated February 15, 2019, on the effectiveness of internal control over financial reporting as of December 29, 2018, contains an explanatory paragraph that states the scope of management’s assessment of the effectiveness of internal control over financial reporting excluded SodaStream International Ltd. and its subsidiaries (“SodaStream”), which the Company acquired in December 2018. SodaStream’s total assets and net revenue represented approximately 5% and 1 %, respectively, of the consolidated total assets and net revenue of PepsiCo, Inc. as of and for the year ended December 29, 2018. Our audit of internal control over financial reporting of PepsiCo, Inc. also excluded an evaluation of the internal control over financial reporting of SodaStream.

 

 

/s/ KPMG LLP

 

 

New York, New York

 

November 18, 2019

 

 



EX-25.1 8 a2240066zex-25_1.htm EX-25.1

Exhibit 25.1

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM T-1

 

STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE

 

CHECK IF AN APPLICATION TO DETERMINE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2)           
o

 


 

THE BANK OF NEW YORK MELLON

(Exact name of trustee as specified in its charter)

 

New York
(Jurisdiction of incorporation
if not a U.S. national bank)

 

13-5160382
(I.R.S. employer
identification no.)

 

 

 

240 Greenwich Street, New York, N.Y.
(Address of principal executive offices)

 

10286
(Zip code)

 


 

PepsiCo, Inc.

(Exact name of obligor as specified in its charter)

 

North Carolina
(State or other jurisdiction of
incorporation or organization)

 

13-1584302
(I.R.S. employer
identification no.)

 

 

 

700 Anderson Hill Road
Purchase, New York

(Address of principal executive offices)

 

10577
(Zip code)

 


 

Debt Securities
(Title of the indenture securities)

 

 

 


 

1.                                      General information.  Furnish the following information as to the Trustee:

 

(a)                                 Name and address of each examining or supervising authority to which it is subject.

 

Name

 

Address

 

 

 

Superintendent of the Department of Financial Services of the State of New York

 

One State Street, New York, N.Y. 10004-1417, and Albany, N.Y. 12223

 

 

 

Federal Reserve Bank of New York

 

33 Liberty Street, New York, N.Y. 10045

 

 

 

Federal Deposit Insurance Corporation

 

550 17th Street, NW
Washington, D.C. 20429

 

 

 

The Clearing House Association L.L.C.

 

100 Broad Street
New York, N.Y. 10004

 

(b)                                 Whether it is authorized to exercise corporate trust powers.

 

Yes.

 

2.                                      Affiliations with Obligor.

 

If the obligor is an affiliate of the trustee, describe each such affiliation.

 

None.

 

16.                               List of Exhibits.

 

Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d).

 

1.                                      A copy of the Organization Certificate of The Bank of New York Mellon (formerly known as The Bank of New York, itself formerly Irving Trust Company) as now in effect, which contains the authority to commence business and a grant of powers to exercise corporate trust powers. (Exhibit 1 to Amendment No. 1 to Form T-1 filed with Registration Statement No. 33-6215, Exhibits 1a and 1b to Form T-1 filed with Registration Statement No. 33-21672, Exhibit 1 to Form T-1 filed with Registration Statement No. 33-29637, Exhibit 1 to Form T-1 filed with Registration Statement No. 333-121195 and Exhibit 1 to Form T-1 filed with Registration Statement No. 333-152735).

 

2


 

4.                                      A copy of the existing By-laws of the Trustee (Exhibit 4 to Form T-1 filed with Registration Statement No. 333-229494).

 

6.                                      The consent of the Trustee required by Section 321(b) of the Act (Exhibit 6 to Form T-1 filed with Registration Statement No. 333-229519).

 

7.                                      A copy of the latest report of condition of the Trustee published pursuant to law or to the requirements of its supervising or examining authority.

 

3


 

SIGNATURE

 

Pursuant to the requirements of the Act, the Trustee, The Bank of New York Mellon, a corporation organized and existing under the laws of the State of New York, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of New York, and State of New York, on the 12th day of November, 2019.

 

 

THE BANK OF NEW YORK MELLON

 

 

 

 

By:

/s/ Francine Kincaid

 

 

Name:

Francine Kincaid

 

 

Title:

Vice President

 

4


 

EXHIBIT 7

 

Consolidated Report of Condition of

 

THE BANK OF NEW YORK MELLON

 

of 240 Greenwich Street, New York, N.Y. 10286
And Foreign and Domestic Subsidiaries,

 

a member of the Federal Reserve System, at the close of business September 30, 2019, published in accordance with a call made by the Federal Reserve Bank of this District pursuant to the provisions of the Federal Reserve Act.

 

 

 

Dollar amounts in thousands

 

ASSETS

 

 

 

Cash and balances due from depository institutions:

 

 

 

Noninterest-bearing balances and currency and coin

 

5,960,000

 

Interest-bearing balances

 

91,499,000

 

Securities:

 

 

 

Held-to-maturity securities

 

33,769,000

 

Available-for-sale securities

 

86,659,000

 

Equity securities with readily determinable fair values not held for trading

 

48,000

 

Federal funds sold and securities purchased under agreements to resell:

 

 

 

Federal funds sold in domestic offices

 

0

 

Securities purchased under agreements to resell

 

30,340,000

 

Loans and lease financing receivables:

 

 

 

Loans and leases held for sale

 

0

 

Loans and leases held for investment

 

25,722,000

 

LESS: Allowance for loan and lease losses

 

101,000

 

Loans and leases held for investment, net of allowance

 

25,621,000

 

Trading assets

 

4,410,000

 

Premises and fixed assets (including capitalized leases)

 

2,653,000

 

Other real estate owned

 

2,000

 

Investments in unconsolidated subsidiaries and associated companies

 

1,764,000

 

Direct and indirect investments in real estate ventures

 

0

 

Intangible assets:

 

6,997,000

 

Other assets

 

14,374,000

 

Total assets

 

304,096,000

 

 


 

LIABILITIES

 

 

 

Deposits:

 

 

 

In domestic offices

 

143,571,000

 

Noninterest-bearing

 

53,707,000

 

Interest-bearing

 

89,864,000

 

In foreign offices, Edge and Agreement subsidiaries, and IBFs

 

111,933,000

 

Noninterest-bearing

 

3,725,000

 

Interest-bearing

 

108,208,000

 

Federal funds purchased and securities sold under agreements to repurchase:

 

 

 

Federal funds purchased in domestic offices

 

3,578,000

 

Securities sold under agreements to repurchase

 

1,375,000

 

Trading liabilities

 

2,627,000

 

Other borrowed money:
(includes mortgage indebtedness and obligations under capitalized leases)

 

7,503,000

 

Not applicable

 

 

 

Not applicable

 

 

 

Subordinated notes and debentures

 

0

 

Other liabilities

 

7,506,000

 

Total liabilities

 

278,093,000

 

 

 

 

 

EQUITY CAPITAL

 

 

 

Perpetual preferred stock and related surplus

 

0

 

Common stock

 

1,135,000

 

Surplus (exclude all surplus related to preferred stock)

 

11,107,000

 

Retained earnings

 

15,167,000

 

Accumulated other comprehensive income

 

-1,406,000

 

Other equity capital components

 

0

 

Total bank equity capital

 

26,003,000

 

Noncontrolling (minority) interests in consolidated subsidiaries

 

0

 

Total equity capital

 

26,003,000

 

Total liabilities and equity capital

 

304,096,000

 

 


 

I, Michael Santomassimo, Chief Financial Officer of the above-named bank do hereby declare that this Report of Condition is true and correct to the best of my knowledge and belief.

 

 

Michael Santomassimo

 

Chief Financial Officer

 

We, the undersigned directors, attest to the correctness of this statement of resources and liabilities. We declare that it has been examined by us, and to the best of our knowledge and belief has been prepared in conformance with the instructions and is true and correct.

 

 

 

 

Thomas P. Gibbons

 

 

Samuel C. Scott

 

                                                  Directors

Joseph J. Echevarria

 

 

 

 

 

 



GRAPHIC 9 g329195.jpg G329195.JPG begin 644 g329195.jpg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end